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1 Introduction 
Glucosinolates, also known as mustard oils, are a small but diverse class of sulfur 
and nitrogen containing secondary metabolites. They can be found in Brassicaceae 
and related plant families including important crop plants and vegetables, such as 
oilseed rape or cabbage. Their potential as a plant-defence system, along with recent 
findings suggesting cancer-protective properties of a glucosinolate-rich diet, led to an 
increased interest in this class of compounds. Substantial progess has thereby been 
achieved using the model plant Arabidopsis thaliana, which allowed unravelling the 
core biosynthesis pathway. 
1.1  Glucosinolate biosynthesis 
The precursors of glucosinolate biosynthesis are a few protein amino acids, mainly 
methionine, phenylalanine and tryptophan. Depending on the nature of the amino 
acid residue, the glucosinolates are classified as aliphatic, aromatic and indolic 
glucosinolates, respectively. The glucosinolate biosynthesis proceeds in three steps: 
(i) side-chain elongation of amino acids, (ii) formation of the core structure and (iii) 
secondary side-chain modifications, where step (i) and (iii) give rise to the diversity of 
these compounds. 
The enzymes mediating the biosynthesis of the core structure have been identified in 
A. thaliana (Fig. 1.1), and cytochrome P450 monooxygenases (CYPs) appeared to 
play a predominant role. CYP79F1 and CYP79F2 convert chain-elongated 
methionine to the aliphatic aldoxime (Reintanz et al., 2001; Hansen et al., 2001a; 
Chen et al., 2003; Tantikanjana et al., 2004), CYP79B2 and CYP79B3 mediate the 
formation of indole-3-acetaldoxime (IAOx) from tryptophan (Mikkelsen et al., 2000; 
Hull et al., 2000). The subsequent reaction giving rise to an aci-nitro-compound is 
catalysed by CYP83A1 and CYP83B1 in the aliphatic and indolic pathway, 
respectively (Bak et al., 2001; Naur et al., 2003; Hemm et al., 2003). The formation of 
the intermediate S-alkyl thiohydroximate might be a spontaneous reaction or 
dependant on glutathione-S-transferases (GSTs). The C-S lyase and an S-
glucosyltransferase (UGT) catalyze the subsequent synthesis of the thiohydroximate 
and the desulfo-glucosinolate, respectively (Mikkelsen et al., 2004; Grubb et al., 
2004). Finally, sulfotransferases mediate the last step of the core pathway resulting in 
1 Introduction   2
the synthesis of the parent glucosinolate (Piotrowski et al., 2004; Klein et al., 2006), 
which can undergo secondary modifications. 
 
1.2  A link between indolic glucosinolate, IAA and camalexin 
biosynthesis 
Analyses of mutants defective in the biosynthesis of indolic glucosinolates have 
revealed a tight link with auxin biosynthesis, since both pathways share the same 
Figure 1.1: Schematic representation of the aliphatic and indolic glucosinolate biosynthesis.
ASA1, anthranilate synthase alpha 1; TSB1, tryptophan synthase beta 1; CYP, cytochrome
P450 monooxygenase; UGT, S-glycosyltransferase; AtST, A. thaliana sulfotransferase.  
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precursors (Fig. 1.2). Knock-out plants of cyp83b1 and the C-S lyase were initially 
described as superroot (sur) mutants, with respect to their increased number of 
lateral and adventitious roots (Delarue et al., 1998; Barlier et al., 2000; Mikkelsen et 
al., 2004). Besides the observed root morphology, sur mutants showed elongated 
hypocotyls and epinastic cotyledons. The observed phenotype thereby resembled 
that of wild-type seedlings grown on auxin containing media. Indeed, the sur mutants 
contained an elevated indole-3 acetic acid (IAA) level compared to wild-type plants. 
Moreover, partial or complete blockage of the indolic glucosinolate biosynthesis led to 
a redirection of IAOx into the IAA biosynthesis pathway, leaving to a high-auxin 
phenotype (Bak et al., 2001). Further evidence for an increased IAA accumulation in 
response to an impaired indolic glucosinolate biosynthesis, is provided by studies of 
an ugt74b1 mutant line, with stunted, mal formed plants (Grubb et al., 2004). 
Figure 1.2: Simplified model of the IAA synthesis pathways in A. thaliana (modified after 
Zhao et al., 2002; Woodward and Bartel, 2005; Pollmann et al., 2006). Question marks
indicate pathways with unknown enzymes. ASA1, anthranilate synthase alpha 1; ASB1, 
anthranilate synthase beta 1; TSB1, tryptophan synthase beta 1; CYP, cytochrome P450 
monooxygenase; UGT, S-glycolsytransferase; AtST, A. thaliana sulfotransferase; NIT, 
nitrilase; MYR, myrosinase; AAO1, indole-3-acetaldehyde oxidase, YUCCA, flavin 
monooxygenase-like protein; IAOx, indole-3-acetaldoxime; I3M, indole-3-ylmethyl 
glucosinolate; IAAId, indole-3-acetaldehyde; IAA, indole-3-acetic acid; IAN; indole-3-
acetonitrile. 
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However, the pleiotropic phenotype of this mutant is caused by both, an 
accumulation of the thiohydroximate, and an increased auxin level.  
An opposite effect was reported for a cyp79b2/cyp79b3 double knock-out mutant, 
which contained slightly decreased IAA concentrations (Zhao et al., 2002). 
Nevertheless, the mutants were still able to produce sufficient amounts of IAA for 
plant growth and reproduction. A reason for that is the existence of multiple pathways 
for IAA biosynthesis. One possibility is the tryptophan-independent pathway; another 
way uses tryptophan as precursor and converts it to IAOx via tryptamine. The key 
enzyme is the flavin monooxygenase YUCCA. Even though this pathway also 
produces IAOx and is still functional in cyp79b2/cyp79b3 knock-out mutants, these 
plants do not contain any detectable indolic glucosinolates (Zhao et al., 2002). 
Consequently, IAOx produced by CYP79B2 and CYP79B3 appears to be the sole 
source for indolic glucosinolate biosynthesis, whereas the IAOx pool derived from the 
YUCCA pathway is exclusively shuttled into IAA synthesis. Besides IAA and indolic 
glucosinolate biosynthesis, IAOx also serves as precursor for camalexin (Glawischnig 
et al., 2004), the main phytoalexin of the model plant A. thaliana, and like indolic 
glucosinolates involved in the biotic stress response. The rate-limiting step in 
camalexin biosynthesis is catalysed by CYP71B15 (Schuhegger et al., 2006) and the 
precursor IAOx seems to be solely derived from the CYP79B2/CYP79B3 pool, since 
the cyp79b2/cyp79b3 double knock-out contained no detectable amounts of 
camalexin (Glawischnig et al., 2004). Hence, IAOx constitutes an important 
branching point of several pathways derived from tryptophan. 
A further link between synthesis of the precursor tryptophan and IAA accumulation 
could be observed in the cyp83b1 mutant. The increased IAA content was 
accompanied by an upregulation of ASA1 (Smolen and Bender, 2002), coding for the 
feedback-regulated subunit of anthranilate synthase. Along with that, the cyp83b1 
phenotype could be partially rescued by complementation with asa1 knock-out 
mutants (Stepanova et al., 2005). This suggests that an increased auxin synthesis is 
strictly dependent on high ASA1 transcription. Accordingly, heterologous expression 
of a feedback-insensitive ASA1 subunit from rice in A. thaliana led to high tryptophan 
and auxin levels in transgenic plants (Ishihara et al., 2006). Taken together, 
tryptophan biosynthesis is not only important for providing the amino acid for protein 
synthesis, but there is a tight connection with the synthesis of indolic glucosinolates, 
camalexin and auxin that are derived from tryptophan. 
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1.3  The biological role of glucosinolates 
The capacity of plants to synthesise glucosinolates co-occurs with the expression of 
myrosinases. These are special β-thioglucoside glycohydrolases (also called TGGs), 
located in idioblasts (myrosin-cells) scattered throughout most tissues that 
accumulate glucosinolates (Husebye et al., 2002; Barth and Jander, 2006). Upon 
tissue rupture, the biologically inactive glucosinolates come in contact with 
myrosinases, which catalyze the hydrolysis of the glucose residue. The unstable 
aglucone subsequently gives rise to various biologically active breakdown products, 
including nitriles, thiocyanates and isothiocyanates among others. The nature of the 
breakdown product thereby depends on the surrounding conditions, such as pH, the 
presence of ferrous ions or myrosinase interacting proteins (Wittstock and Halkier, 
2002; Bones and Rossiter, 2006).  
The bipartite glucosinolate-myrosinase symstem has also implications for human 
nutrition. The uptake and bioavailability of glucosinolates and their breakdown 
products not only depend on the respective vegetable consumed, but also on growth 
conditions, transport, storage and food processing that influence glucosinolate 
concentration and myrosinase activity (Johnson, 2002). In general, isothiocyanates 
are believed to contribute predominantly to the anti-carcinogenic properties of 
Brassica vegetables. Case studies showed a negative correlation between cancer 
development and the uptake and secretion of isothiocyanates due to the 
consumption of glucosinolate-rich food. This could be shown for cancers of the 
respiratory and digestive system, but also for hormone-dependent cancers (review by 
Holst and Williamson, 2004; Keck and Finley, 2004). Interestingly, the protection 
against cancer may be achieved on two different levels of cancer development. First 
of all, isothiocyanates are known to stimulate phase II enzymes in the liver that 
inactivate carcinogens and target them for secretion (Surh, 2003). Second, they have 
been shown to induce apoptosis in cancer cell lines (Pledgie-Tracy et al., 2007). 
Isothiocyanates might therefore not only inhibit cancer development but also reduce 
tumor growth and promotion.  
Unlike the beneficial effects of moderate glucosinolate intake in human nutrition 
through Brassica vegetables, high ingestion can have adverse effects on animal 
health when large amounts of Brassica crops are used as fodder. Therefore, different 
methods are employed to reduce the glucosinolate concentration prior to feeding 
(Tripathi and Mishra, 2007). So far, the detoxification of high-glucosinolate crops 
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seems to be the most appropriate way of using them as fodder, since breeding of 
cultivars with lower glucosinolate concentrations might affect the interaction of the 
plant with pathogens and herbivores.  
Indeed, the primary function of the glucosinolate-myrosinase system is thought to be 
the deterrence of attacking herbivores. A high glucosinolate concentration acts as 
deterrent against generalist herbivores (Kliebenstein et al., 2002a). However, not only 
the absolute concentration, but rather the composition of the produced glucosinolates 
is crucial for plant-herbivore interaction (Mewis et al., 2006; Zhang et al., 2006). Kim 
and Jander (2007) could show that A. thaliana responds to attack by the green peach 
aphid (Myzus persicae) not with an increased glucosinolate biosynthesis but with the 
conversion of indole-3-ylmethyl glucosinolate (I3M) to 4-methoxyindol-3-ylmethyl 
glucosinolate (4MOI3M), which is a more potent aphid deterrent than I3M. In contrast 
to generalist herbivores, specialists have evolved various systems to overcome the 
glucosinolate-myrosinase system and have learned to take advantage of it. Certain 
specialist herbivores are able to secrete the glucosinolates and use them for their 
own defense (Muller et al., 2001), others express enzymes for the detoxification of 
glucosinolates (Ratzka et al., 2002; Wittstock et al., 2004). The glucosinolate profile 
can thereby be used by specialists for host-plant recognition and may function as an 
oviposition or feeding signal (Rask et al., 2000; Ulmer and Dosdall, 2006). Altering 
the glucosinolate profile of crop cultivars in combination with the growth of trap plants 
might therefore be a potential tool to delimit herbivory by specialists (Cook et al., 
2006). A further possibility to reduce the damage by specialists is already present in 
nature. Volatiles released during herbivore attack can in turn attract natural enemies 
of the herbivore feeding on the plant (Agrawal, 2000). This offers plants a further 
possibility for the defence against specialist herbivores that are unaffected by high 
glucosinolate concentrations.  
Besides the role of glucosinolates in the plant-insect interaction, there is emerging 
evidence that also microbial pathogens are affected by glucosinolates. Treatment 
with bacterial pathogens or oomycetes triggered an accumulation of indolic 
glucosinolates in leaves and roots of A. thaliana, respectively (Brader et al., 2001; 
Bednarek et al., 2005) and a role of indolic glucosinolates as defence compounds 
was demonstrated upon infection with the fungal pathogen Botrytis cinerea, which 
was shown to produce larger lesions on low indolic glucosinolate mutants 
(Kliebenstein et al., 2005). Moreover, in vitro experiments showed adverse effects of 
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aliphatic isothiocyanates, mainly 4-methylsulphinylbutyl isothiocyanate, on the growth 
of various plant pathogens, including bacteria and fungi (Tierens et al., 2001). 
Therefore, it seems that different glucosinolates and their breakdown products have 
the potential to differentially influence the plant-pathogen interaction. Indeed, an 
alteration of the glucosinolate profile of A. thaliana by introducing new pathway 
enzymes was proven to enhance the resistance against various pathogens (Brader et 
al., 2006). Tailor-made glucosinolate compositions might also find application in 
agronomically important Brassica species. Besides the cultivation of Brassica 
vegetables and crops, the use of glucosinolate-containing plants in the so-called 
biofumigation has gained increasing interest. This describes the use of green manure 
derived from Brassica species to suppress soil-borne pests, ranging from bacteria, 
fungi and nematodes to insects (Matthiessen and Shackleton, 2005; Matthiessen and 
Kirkegaard, 2006). 
Taken together, the concentration and more important the composition of 
glucosinolates in Brassica species is an important factor when it comes to pest 
management but also with regard to animal and human nutrition. One way to control 
the accumulation of glucosinolates would be the manipulation of existing or 
introduction of novel pathway enzymes (Feldmann 2001; Brader et al., 2006). 
However, a further possibility would be to alter the expression of multiple enzymes at 
the same time by manipulating a regulator of the specific pathway (Endt et al., 2002; 
Broun, 2004).  
1.4  The regulation of glucosinolate biosynthesis 
The glucosinolate concentration and profile of A. thaliana not only differs among 
different organs and tissues, but also during plant development or in response to 
environmental stimuli (Petersen et al., 2002; Brown et al., 2003; previous section). 
Furthermore, indolic glucosinolate and IAA biosynthesis are tightly connected but 
differ with regard to relative abundance, spatial distribution, developmental control 
and responsiveness to environmental stimuli. Hence, a complex regulatory network 
controlling these processes can be expected. However, only few components 
involved in the regulation of glucosinolate and/or IAA accumulation have been 
identified to date. 
IQD1 is a nuclear-localised calmodulin-binding protein, identified in a screen for 
mutants with increased glucosinolate accumulation (Levy et al., 2005). 
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Overexpression of IQD1 results in increased levels of aliphatic and indolic 
glucosinolates. However, only genes coding for key enzymes of the indolic pathway 
were upregulated, the respective structural genes of the aliphatic pathway were 
downregulated, and the authors speculate about a possible feedback regulation of 
the two pathways. Nevertheless, the high glucosinolate phenotype was accompanied 
by an increased resistance against two generalist herbivores and IQD1 transcription 
is induced by mechanical stimuli. Therefore, it might play a role in the biotic stress 
response. 
A second putative component of the regulatory network controlling glucosinolate 
biosynthesis might be OBP2. OBP2 is a member of the DNA-binding-with-one-finger 
(DOF) transcription factor family and was shown to induce the transcription of at least 
several genes involved in glucosinolate biosynthesis, mainly CYP83B1 (Skirycz et al., 
2006). Constitutive OBP2 overexpression lines were characterised by moderately 
increased levels of short-chain aliphatic and indolic glucosinolates, but also by an 
elevated IAA concentration and an altered growth phenotype with small, curly leaves. 
OBP2 transcription is activated by methyl jasmonate treatment, in response to 
wounding or herbivore attack. However, the effect on the transcript level was only 
seen several hours after treatment. Therefore, OBP2 might not be part of an 
immediate response to biotic challenge.  
Two further regulators of glucosinolate biosynthesis, mainly the indolic pathway, were 
originally identified as altered tryptophan regulation (atr) mutants. ATR1 codes for an 
R2R3-type MYB transcription factor (ATR1/MYB34; Bender and Fink, 1998; Celenza 
et al., 2005), ATR2 is a member of the basic helix-loop-helix (bHLH) proteins 
(ATR2/bHLH05; Smolen et al., 2002). Both, MYB and bHLH proteins, form two of the 
largest transcription factor families in plants, each with more than 120 members in 
A. thaliana (Stracke et al., 2001; Bailey et al., 2003). The factors, characterised so 
far, indicate diverse roles in plant development (Schmitz and Theres, 2005; 
Schellmann et al., 2007), regulation of secondary metabolism and stress response 
(Winkel-Shirley, 2002; Baudry et al., 2004). Also ATR1/MYB34 and ATR2/bHLH05 
appear to have a regulatory role in plant secondary metabolism. Both mutant lines 
(atr1D and atr2D) are characterised by an increased resistance to the tryptophan 
analogue 5-methyltryptophan (5MT). 5MT is able to feedback-regulate the 
anthranilate synthase alpha subunit (Fig. 1.2) but does not substitute for the 
nutritional role of tryptophan. The atr1D and atr2D lines overcome this toxic effect by 
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a constitutive activation of ASA1 transcription. The dominant mutation in atr2D is 
caused by an amino acid exchange in a conserved domain of ATR2/bHLH05. 
Interestingly, only overexpression of the mutated form (atr2D) but not of the wild-type 
allele (ATR2/bHLH05) leads to a pleiotropic phenotype characterised by the 
upregulation of multiple stress-related genes (Smolen et al., 2002). Therefore, the 
authors speculate whether the observed ASA1 activation might be a secondary 
stress response rather than a direct effect of ATR2/bHLH05. The activation of several 
genes in atr2D might possibly result from a disturbed protein/protein interaction with 
other transcription factors. However, an interaction of ATR2/bHLH05 or the mutated 
protein with ATR1/MYB34 could not be observed in a yeast-two-hybrid assay 
(Smolen et al., 2002), even though the formation of regulatory bHLH/MYB 
heterodimers has been reported in other cases previously (Zimmermann et al., 
2004a; Feller et al., 2006). The atr1D line carries a mutation upstream the 
ATR1/MYB34 ORF, leading to a constitutively high expression level (Bender and 
Fink, 1998). The mutation results in an increased accumulation of indolic 
glucosinolates and IAA, caused by an activation of pathway genes (Celenza et al., 
2005). The gene-to-trait relation was confirmed by ectopic overexpression of 
ATR1/MYB34 and in a loss-of-function mutant. Interestingly, the atr1-1 knock-out line 
could complement the high auxin phenotype of the cyp83b1 mutant, indicating an 
important role of ATR1/MYB34 in the homeostasis of indolic glucosinolate and IAA 
biosynthesis. 
Even though several players of a regulatory network controlling indolic glucosinolate 
biosynthesis and accumulation have been identified to date, they do not solely 
account for the complex regulation observed. Aim of the presented study was the 
identification of further components, accounting for the coordinate regulation of 
indolic glucosinolate biosynthesis and the characterisation of such regulators with 
respect to their role in planta and possible interactions with known regulators. To this 
end, multiple strategies were applied to characterise an activation-tagging line with 
an altered glucosinolate accumulation. Biochemical analyses were used to study the 
mutant chemotype in detail, and molecular biology approaches were employed to 
identify the underlying genotype and further investigate the influence of the altered 
expression profile in planta.  
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2  Material and Methods 
2.1  Material 
2.1.1  Chemicals, enzymes, oligo nucleotides 
Unless otherwise stated, all chemicals were of analytical purity. Chemicals, 
laboratory equipment and enzymes were purchased from the following companies:  
Amersham Pharmacia Biotech UK Ltd (Buckinghamshire, GB); Biorad (München, D);  
Roche (Mannheim, D); Difco (Hamburg, D); Duchefa (Haarlem, NL); DuPont 
Company (Wilmigton, GB); Fermentas GmBH (St. Leon-Rot, D); Fluka AG (CH); 
GibcoBRL (Karlsruhe, D); Heraeus (Düsseldorf, D); Intas (Göttingen, D); Merck 
(Darmstadt, D); Invitrogen Life Technologies (Karlsruhe, D); Molecular Dynamics 
(Krefeld, D); New England Biolabs (Schwalbach, D); Promega (Mannheim, D); 
Qiagen GmbH (Hilden, D); Roche (Mannheim, D); Roth (Karlsruhe, D); Sarstedt 
(Nümbrecht, D); Schleicher & Schuell (Dassel, D); Serva (Heidelberg, D); Sigma-
Aldrich (Taufkirchen, D); Stratagene Europe (Amsterdam, NL). 
 
The following kits were used according to the manufacturer’s instructions: 
QIAquick Gel Extraction Kit (Qiagen GmbH, Hilden, D) 
QIAquick PCR Purification Kit (Qiagen GmbH, Hilden, D) 
Quantum Prep Plasmid Miniprep Kit (BioRad, München, D) 
Quiagen Plasmid Midi Kit (Qiagen GmbH, Hilden, D) 
pENTR/D-TOPO® cloning Kit (Invitrogen Life Technologies, Karlsruhe, D) 
Gateway® LR clonaseTM Enzyme Mix (Invitrogen Life Technologies, Karlsruhe, D) 
Gateway® BP clonaseTM Enzyme Mix (Invitrogen Life Technologies, Karlsruhe, D) 
Big Dye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, 
USA) 
Agilent Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies, 
Böblingen, D) 
BCATM Protein Assay Kit (Pierce, Rockford, USA) 
 
Oligo nucleotides were purchased from Metabion (Martinsried, D) and are listed in 
the appendix. 
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2.1.2  Media, buffers 
All media and buffers were prepared with deionised water purified with a Milli-Q Plus 
PF system (Millipore, Schwalbach, D). Media were sterilised by autoclaving, heat-
sensitive substances were filter sterilised. Unless otherwise stated solid media were 
prepared with 1% (w/v) agar. Plates used for the vertical growth of plant seedlings 
were prepared with 0.7% (w/v) gelrite. 
Frequently used media and buffers: 
 
TAE 40 mM Tris-Acetate, pH 7.5, 1 mM EDTA 
 
TE 10 mM Tris-HCl, pH 8, 1 mM EDTA 
 
LB 1% (w/v) bacto tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl 
 
SOC 2% (w/v) bacto tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4x7H2O, 20 mM glucose 
 
YEB 0.5% (w/v) bacto peptone, 0.5% (w/v) beef extract, 0.1% (w/v) yeast 
extract, 0.5% (w/v) sucrose, 0.05% (w/v) MgSO4x7H2O 
 
MGL 0.5% (w/v) bacto tryptone, 0.25% (w/v) yeast extract, 0.5% (w/v) 
NaCl, 0.5% (w/v) mannitol, 0.116% (w/v) sodium glutamate, 0.025% 
(w/v) KH2PO4, 0.01% (w/v) MgSO4, 1 mg/L biotin 
 
YPAD 2% (w/v) bacto peptone, 1% (w/v) yeast extract, 100 mg/L adenine, 
pH 5.8; After autoclaving 40% (w/v) filter sterilised glucose was 
added to a final concentration of 2% (w/v). 
 
SD-medium 
(yeast 
selection 
medium) 
6.7 g/L yeast nitrogen base w/o amino acids (Difco), 0.6 g/L DO 
Supplement -Ade/-His/-Leu/-Trp (BD Biosciences Clontech, Palo 
Alto, USA), pH 5.8; 
The amino acids used for negative selection were not added to the 
medium, the others at the given concentrations: 
Adenine (100 mg/L), Histidine (20 mg/L), Leucine (100 mg/L), 
Tryptophan (50 mg/L); 
After autoclaving 40% (w/v) filter sterilised glucose was added to a 
final concentration of 2% (w/v); 
For SD -His medium, 1M filter sterilised 3-amino-1,2,4-triazole(3-AT)    
was added to a final concentration of 5 mM. 
 
Germination 
medium 
2.2 g/L MS (245, Duchefa, Haarlem, NL), 1% (w/v) sucrose, pH 5.6; 
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2.1.3  Antibiotics 
Antibiotics and their concentration used for the selection of positive transformed 
E. coli and A. tumefaciens: 
Kanamycin 50 µg/mL 
Ampicillin 50 µg/mL 
Carbenicillin 50 µg/mL (E. coli); 100 µg/mL (A. tumefaciens) 
Hygromycin 50 µg/mL 
Chloramphenicol 10 µg/mL (E. coli); 75 µg/mL (A. tumefaciens) 
Rifampicin 150 µg/mL (A. tumefaciens strain GV3101); 
20 µg/mL (A.fumefaciens strain LB A4404.pBBR1MCS 
virGN54D 
Gentamycin 10 µg/mL (E. coli); 25 µg/mL (A. tumefaciens) 
 
2.1.4  Organisms 
2.1.4.1  Bacterial strains 
Strain / Purpose Genotype (Reference) 
Escherichia coli 
DH5α/ 
Plasmid amplification 
F- Φ 80dlacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 
endA1 hsdR17(rK- mK+) phoA supE44 λ- thi-1 gyrA96 relA1; 
(Hanaha, 1983) 
TOP10/ 
Plasmid amplification 
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ 80dlacZΔM15 ΔlacX74 
recA1 araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG; (Invitrogen) 
DB3.1/ 
Propagation of ccdB 
containing plasmid 
F- gyrA462 endA1 Δ(sr1-recA) mcrB mrr hsdS20(rB-, mB-) 
supE44 ara-14 galK2 lacY1 proA2 rpsL20(SmR) xyl-5 λ- 
leu mtl1; (Invitrogen) 
Agrobacterium tumefaciens 
GV3101/ 
Stable plant 
transformation 
RifR, GentR,; 
(Koncz and Schell,1986) 
LB 
A4404.pBBR1MCS 
virGN54D/ 
Leaf infiltration and 
cell culture 
transformation 
RifR, ChlorR; 
(van der Fits et al., 2000) 
 
2.1.4.2  Yeast strains (Saccharomyces cerevisiae) 
Strain Genotype  (Reference) 
Y187 MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, 
gal4 Δ, met-, gal80 Δ,URA3::GAL1UAS-Gal1TATA-lacZ, 
MEL1; 
(Harper et al., 1993) 
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AH109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4 Δ, 
gal80 Δ, Lys2::GAL1UASGAL1TATA-HIS3, MEL1, 
GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-
MEL1TATA-lacZ; 
(James et al., 1996) 
 
2.1.4.3  Yeast cDNA libraries for yeast-two-hybrid assays  
Library Source 
Ara 446 
 
A. thaliana suspension culture grown in darkness; 
K.Salchert, AG C. Koncz, MPIZ Cologne 
Ara-1101 
 
Clontech Matchmaker cDNA Library; green leaf material 
from A. thaliana; 3-week-old plants, ecotype Columbia; 
(Clontech) 
HS-Ara1 
 
polyT-cDNA from whole plants of A. thaliana, ecotype 
Columbia; Hans Sommer, MPIZ Cologne 
The yeast-two-hybrid screens with these libraries were performed by the AG Uhrig, 
University of Cologne. 
2.1.4.4  Arabidopsis thaliana  
All plants and suspension cell cultures used or generated were in the background of 
Arabidopsis thaliana L.Heyn cv. Columbia (NASC-Nr. N1093). 
Public available transgenic lines used in this study were: 
Line 19.4,TAMARA activation tagging population (Schneider et al., 2005), 
Line 228B12, GABI-Kat collection (Rosso et al., 2003). 
2.1.4.5  Nicotiana benthamiana 
Wild type plants (cv. Samsun) were used for leaf infiltration with Agrobacteria. The 
Bright Yellow cell culture (BY2) was used for subcellular localisation of fluorescent 
fusion proteins. 
2.1.5  Vectors 
2.1.5.1  Bacteria vectors 
Vector Source Cloning purpose 
pENTR/D-
TOPO 
Invitrogen Creating a Gateway compatible entry 
clone 
pDONR207 Invitrogen Creating a Gateway compatible entry 
clone 
pGWB1 T. Nakagawa, 
Shimane University 
Gateway compatible binary destination 
vector, no promoter, no tag 
pGWB2 T. Nakagawa, 
Shimane University 
In planta overexpression under control 
of the CaMV 35S promoter 
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pGWB3 T. Nakagawa, 
Shimane University 
In planta expression of the uidA 
reporter gene driven by the cloned 
promoter 
pGWB3i T. Nakagawa, 
Shimane University, 
modified (Berger et 
al., 2007) 
In vivo expression of the uidA reporter 
gene containing an intron to prevent 
expression in Agrobacteria 
pGWB5 T. Nakagawa,  
Shimane University 
Expression of translational GFP fusion 
proteins for subcellular localisation 
pSPYN Klaus Harter, 
University of 
Tuebingen 
Bimolecular fluorescence assay, “split-
YFP”, translational fusion with the YFP 
N-terminus 
pSPYC Klaus Harter, 
University of 
Tuebingen 
Bimolecular fluorescence assay, “split-
YFP”, translational fusion with the YFP 
C-terminus 
pUCΔalcAN Caddick et al., 1998 Ethanol inducible expression system 
pBinΔalc-R Caddich et al., 1998 Ethanol inducible expression system 
2.1.5.2  Yeast vectors 
Vector Source Cloning purpose 
pCD2-attR Joachim Uhrig,  
University of Cologne 
Gateway compatible yeast expression 
vector for construction of yeast-two-
hybrid bait constructs; Trp1+ 
pC-ACT2-attR Joachim Uhrig, 
University of Cologne 
Gateway compatible yeast expression 
vector for construction of yeast-two-
hybrid prey vectors / libraries; Leu2+ 
pACT Joachim Uhrig, 
University of Cologne 
Classical yeast expression vector used 
as empty control and for “gap repair” 
pAS-SNF1 Joachim Uhrig, 
University of Cologne 
Bait vector interacting with SNF4, used 
as positive control 
pACT-SNF4 Joachim Uhrig, 
University of Cologne 
Prey vector interacting with SNF1, 
used as positive control 
 
2.2  Methods 
2.2.1 Methods working with bacteria 
2.2.1.1  Preparation of chemically competent E. coli cells 
The protocol was adapted from Inoue et al. (1990) and slightly modified. 
Several E. coli colonies were inoculated in 250 mL LB (supplemented with 50 mM 
MgCl2 ) and grown at 18°C until an OD600 of 0.6. The suspension was chilled on ice 
for 10 min, distributed to 50 mL tubes and centrifuged at 4500 g in a cooled 
centrifuge. The pellets were resuspended in 80 mL ice-cold TB buffer (10 mM Pipes, 
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55 mM MnCl2, 15 mM CaCl2, 250 mM KCl) and incubated on ice for another 10 min. 
The cells were harvested by centrifugation and resuspended in 20 mL ice cold TB 
buffer. DMSO was slowly added to a final concentration of 7% (v/v). The cell 
suspension was incubated on ice for 10 min. Aliquots of 100 µL were frozen in liquid 
nitrogen and kept at -80°C until use. 
2.2.1.2  Transformation of chemically competent E. coli cells 
An aliquot of chemical competent E. coli cells was thawed on ice and about 200 ng of 
vector DNA were added. After 30 min on ice, the cells were heat-shocked by 
incubation for 30-60 sec at 42°C and cooled immediately on ice for about one minute. 
The cells were recovered in 900 µL LB or SOC medium and incubated at 37°C for 
one hour with gentle shaking. For selection of positive transformands, an aliquot of 
the cells was plated on solid LB medium containing the respective antibiotics and 
incubated overnight at 37°C. 
2.2.1.3  Preparation of electro-competent Agrobacteria 
A preculture of Agrobacteria was diluted in 100 mL MGL medium (OD600 of 0.04-0.08) 
and grown for about 4 h to an OD600 of 0.5. Subsequently, all steps were performed 
on ice and a cooled centrifuge was used. The cells were harvested by centrifugation 
and resuspended in 40 mL 1 mM HEPES, pH 7. After that, three further washing 
steps followed. Each time, the cells were centrifuged and resuspended in 1 mM 
HEPES, pH 7, 10% (v/v) glycerol, decreasing the volume from 40 mL to 2 mL and 
1mL, respectively. 50 µL aliquots of the final cell suspension were snap frozen in 
liquid nitrogen and stored at -80°C until use. 
2.2.1.4  Transformation of electro-competent Agrobacteria 
Electro competent Agrobacteria were thawed on ice and about 50-200 ng vector DNA 
were added. The cells were transferred to a chilled electroporation chamber (2 mm 
gap) and subjected to electroporation (25 µF, 400 Ω, 2.5 kV pulse for about 2 sec). 
Immediately, 1 mL YEB medium at RT was added and the cells were allowed to 
recover for 2 hours at 28°C with gentle shaking. Positive transformands were 
selected by plating an aliquot on solid YEB medium containing the respective 
antibiotics and incubation for 2 days at 28°C. 
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2.2.2  Methods working with yeast 
2.2.2.1  Yeast transformation on small scales 
Small scale preparation of competent cells and yeast transformation was performed 
according to the LiAc method described by Gietz et al. (1995). About 200-500 ng 
plasmid DNA were used per transformation. If multiple transformations were done in 
parallel, the DNA was distributed to Eppendorf tubes and the competent yeast cells 
were then added. 
2.2.2.2  Yeast transformation in a multi-well format 
For 100 transformations, 5 mL of an overnight yeast culture were inoculated in 150 
mL YPAD and grown at 30°C for about 4 hours. The cells were harvested by 
centrifugation and washed once in 25 mL H2O. The cells were again centrifuged, the 
supernatant discarded and the pellet resuspended in the remaining liquid. The 
following reagents were added in the given order: 7 mL PEG 3350 (50% w/v); 1.06 
mL 1 M LiAc, pH 7.5; 735 µL single stranded DNA (2 mg/mL); 1.3 mL H2O. The cells 
were resuspended by pipetting and 100 µL competent yeast cells were added to 
each well, already containing the vector DNA. The cells were mixed with the DNA 
and the plates were incubated for 30 min at 30°C, then for 20 min at 42°C. The cells 
were sedimented by centrifugation, the supernatant removed and the pellet mixed 
with 100 µL selection medium. A second plate with a 1:100 dilution in selection 
medium was prepared and both plates were kept at 30°C. After 2-3 days the positive 
transformands were transferred to solid medium plates using a multi-well replicator. 
2.2.2.3  In vivo recombination (“gap repair”) 
Yeast offers the advantage of high frequency homologous recombination. It allows 
therefore the high throughput cloning of PCR fragments into linearised plasmids 
(“gap repair”), given the PCR fragments and plasmid have homologous sequences.  
For this purpose, PCR fragments and a linearised, dephosphorylated plasmid are 
introduced into yeast by co-transformation in a multi-well format (2.2.2.3). 
2.2.2.4  Mating of two haplotypes in a multi-well format 
Introducing two separate plasmids into yeast can be achieved by co-transformation of 
both plasmids into a single yeast strain, or by introducing each construct into yeast 
strains of opposite mating types and subsequent mating of these strains. This allows 
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handling the transformants separate from each other and allows the generation of 
larger numbers of double positive transformants than achieved with the co-
transformation method.  
As well as “gap repair” and yeast transformation, mating can be performed in a multi-
well format. Therefore, colonies of both mating partners were resuspended each in 
50 µL YPAD (PEG 3350 10% (w/v)) and mixed together in a multi-well plate (100 µL 
final volume). The plates were incubated for at least 3 hours at 30°C before the cells 
were transferred to solid selection media with a multi-well replicator. 
2.2.3  Plant methods 
2.2.3.1  Plant growth 
To break the seed dormancy, freshly sawn seeds on either soil or culture plates were 
stratified for 2-4 days in the dark at 4°C. 
2.2.3.1.1 Growth on soil 
Seeds were sawn on humid, freshly prepared A. thaliana or tobacco culture soil and 
covered with a transparent plastic lid for the first days to maintain high humidity. 
Plants were either grown in the greenhouse with a 16 h/8 h light/dark regime and an 
average photon flux density of 150-200 µmol.m-2.s-1, or in a growth cabinet with an 8 
h/16 h light dark cycle and an average photon flux density of 70 µmol.m-2.s-1. The 
temperature was kept at 22°C during the light and 18°C during the dark period. 
Relative humidity was approximately 40%. 
2.2.3.1.2 Growth on sterile culture plates 
Surface sterilised Arabidopsis seeds were plated on solid germination medium and 
incubated in growth cabinets with a 12 h /12 h light dark or a 8 h /16 h light/dark 
regime, and an average photon flux density of 70 µmol.m-2.s-1. For the selection of T1 
transfromands the seeds were mixed with 0.1% (w/v) agarose and evenly distributed 
on germination medium supplemented with 50 µg/mL kanamycin. The resistance of 
seedling to 5-methyl-tryptophan (5MT) was tested by growth on germination medium 
containing 15 µM 5MT. 
2.2.3.1.3 Growth in liquid germination medium 
15 - 25 surface sterilised Arabidopsis seeds were added to 100 mL liquid germination 
medium in a 250 mL Erlenmeyer flask and grown for 7 days under constant light and 
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constant shaking (140 rpm). The concentrations of substances were as indicated for 
growth on solid medium, unless otherwise stated. 
2.2.3.2 Stable plant transformation 
Flowering Arabidopsis plants were transformed by the floral dip method, adapted 
from Clough and Bent (1998). In brief, the respective Agrobacterium strain was 
grown in 300 mL LB medium until OD600 of 0.8-1.0. The cells were harvested by 
centrifugation (2500 g for 15 min at RT) and resuspended in infiltration medium (5% 
(w/v) sucrose, pH 5.7, 0.03% (v/v) Silwet L-77; in tab water) to an OD600 of 0.8. The 
inflorescence of the Arabidopsis plants was submerged in this suspension for 20 sec 
and the plants were afterwards kept horizontally in the dark for one day, prior to 
transfer to the greenhouse. 
2.2.3.3  Transient transformation 
2.2.3.3.1 Transformation of A. thaliana suspension culture (Berger et al., 2007) 
A. thaliana cells were grown in the dark at 22°C with gentle shaking at 160 rpm. The 
cells were inoculated weekly at a 1:5 dilution into fresh medium (4.3 g/L MS basal 
salts (Duchefa, NL), 4 mL/L Gamborg’s vitamin solution (Sigma, Munich, D), 1 mg/L 
2,4-dichlorophenoxyacetic acid (2,4-D), 30 g/L sucrose, pH 5.8). 
The Agrobacteria strains used were the hypervirulent strain LBA4404.pBBR1MCS 
virGN54D (van der Fits et al., 2000) for the effector and reporter vectors and the 
antisilencing strain 19K (Voinnet et al., 2003). Agrobacteria from fresh plates were 
grown overnight in YEB medium with the respective antibiotics. Cells were harvested 
by centrifugation, washed once in the plant cell culture medium and resuspended in 
25 % of the initial culture volume. 25 µL of the 19K strain and 25 µL of the reporter 
and/or effector strains were added to 3 mL of 1:5 diluted plant cell culture in 6 well 
sterile culture plates (Corning Inc., USA). After 3-4 days of co-culture (dark, 22°C, 
160 rpm), 1 mL of each sample was centrifuged and the pellet was stored at -80°C 
until GUS analysis. The remaining cells were treated with 500 µL X-Gluc staining 
solution (50 mM NaH2PO4, pH 7, 1 mM X-Gluc) for one hour to overnight at 37°C in 
the dark (without shaking). 
2.2.3.3.2 A. thaliana and N. benthamiana leaf infiltration with Agrobacteria 
For the transient expression in leaves, A. thaliana and N. benthamiana plants were 
grown in the greenhouse for about 4-6 weeks (vegetative growth phase).  
2 Material and Methods   
 
19
The Agrobacteria (LB A4404.pBBR1MCS virGN54D) carrying the desired constructs 
and the anti-silencing strain 19K were grown overnight in 3-5 mL YEB medium with 
the respective antibiotics. The cells were harvested by centrifugation (15 min, 4000 
rpm) and the supernatant discarded. The Agrobacteria were resuspended in AS 
medium (10 mM MgCl2, 10 mM MES, pH 5.6, 150 µM acetosyringon) and the OD600 
adjusted to 0.7-0.8. The cells were left at RT for about 4 hours. Prior to leaf 
infiltration, the Agrobacteria were mixed in an equimolar ratio and injected into the 
abaxial air space of the leaves using a syringe. The plants were kept in the dark 
overnight and then transferred to the greenhouse. Leaves were analysed about 3-4 
days after infiltration. 
2.2.3.3.3 Transfection of tobacco BY2 protoplasts 
The transfection of BY2 protoplast was performed as described by Sheen (2001), 
based on the PEG mediated transfection with 30 µg of total DNA. 
2.2.3.4 Seed surface sterilisation 
2.2.3.4.1 Wet method 
Arabidopsis seeds were surface sterilized in 3.6% (v/v) sodium hypochlorite, 0.02% 
(v/v) Triton X-100, for 15 min followed by several washes with sterile deionised water. 
2.2.3.4.2 Dry method 
Arabidopsis seeds were distributed into Eppendorf tubes and placed in a glass 
desiccator next to a beaker with 100 mL 12% (v/v) sodium hypochlorite. Three mL 
37% (v/v) hydrochloric acid were added carefully to the sodium hypochlorite and the 
desiccator was closed tightly. The seeds were surface sterilized for at least 4 hours 
up to overnight incubation. The chlorine gas was allowed to evaporate from the 
Eppendorf tubes for 2-3 hours under the cleanbench. 
2.2.3.5 Histochemical GUS analysis, modified after Jefferson et al. (1987) 
Histochemical detection of GUS activity was performed using 5-bromo-4-chloro-3-
indolyl-β-D-glucuronid acid (X-Gluc) as substrate. The plant material was initially 
fixed for about 30 min in Fixans (0.3% (v/v) formaldehyde, 10 mM MES, pH 5.6, 0.3 
M mannitol) and then rinsed in washing buffer (50 mM Na2HPO4, pH 7) for the same 
time. The fixed material was infiltrated with staining solution (50 mM Na2HPO4, pH 7, 
1 mM X-Gluc) and stained overnight at 37°C in the dark. If plant material with a 
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hydrophobic surface was stained (leaf, stem), Triton X-100 was added as surfactant 
to a final concentration of 0.1% (v/v). Chlorophyll of stained sample was removed by 
incubation in 70% (v/v) ethanol until the plant material was clear. The destaining 
process could be accelerated by microwaving the samples in 70% (v/v) ethanol. 
2.2.3.6 Quantitative GUS activity measurement 
Proteins were extracted from leaf of cell pellets in 200-800 µL protein extraction 
buffer (50 mM Na2HPO4, pH 7, 1 mM EDTA, 0.1% (v/v) Triton X-100). The 
homogenate was centrifuged (15 min, 13000 rpm, 4°C) and the clear supernatant 
was used for protein quantification (BCA kit, Pierce, Rockford, USA) with BSA as a 
standard. The GUS activity was determined using 4-methylumbelliferyl-β-D-
glucuronide (MUG) as substrate. The amount of 4-methylumbelliferone (4MU) 
formed, was recorded fluormetrically (Ex 340 nm; Em 465 nm). For this, 200 µL 
substrate buffer (protein extraction buffer with 1 mM MUG) and 25 µL protein extract 
were mixed, incubated at 37°C in the dark and measured every 10-30 min on a 
Tecan multi-well plate reader (Crailsheim, D). 
2.2.3.7 Microscopical documentation 
Fluorescence fusion proteins were analysed with a Nikon Eclipse E800 using a GFP 
specific filter (GFP-BD; EX 460-500; DM 505; BA 510-560). 
GUS stained plant material was either analysed with a Nikon Eclipse E800 
(microscope) or a Nikon SMZ-U (stereoscope).  
Pictures were taken with a 1-CCD colour video camera (KY-F1030; JVC, Singapore) 
operated by the DISKUS software (Technisches Büro Hilger, Königswinter, D). 
2.2.3.8 Hormone treatment of plants 
Arabidopsis plants were treated with hormones either by direct spraying or growth on 
hormone supplemented media. The hormones were used at the given 
concentrations: 
Hormone Concentration used for 
spraying (in 0.1% (v/v) 
ethanol, 0.05% (v/v) 
Tween) 
Concentration added to 
growth media (0.01% (v/v) 
ethanol final concentration) 
1-Aminocyclopropane-
1-carboxylic acid (ACC) 
10 µM 10 µM 
Salicylic acid (SA) 0.5 mM 10 µM 
Methyl jasmonate (MeJ) 0.45 mM 10 µM 
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For spraying experiments, 6-week-old wild type plants (grown under short day 
conditions, vegetative growth phase) were used. The rosettes were sprayed with the 
respective hormone solution to cover each leaf and the plants were kept under a 
transparent lid to maintain vapour and avoid cross contamination with other 
hormones. Samples for RNA extraction were taken after 0, 0.5, 2 and 4 hours. 
For growth on hormone supplemented media, transgenic Arabidopsis plants carrying 
a GUS reporter construct were used. Liquid culture experiments were performed with 
7-day-old seedlings by adding the hormones to the medium yielding the respective 
final concentration. Samples for histochemical GUS staining were taken 0, 4, 24 and 
48 hours after hormone induction. Hormone treatment on solid media was achieved 
by growing seedlings vertically, allowing the roots to grow on top of a sterile filter 
paper, laid on the surface of the medium. For hormone induction, the filter paper was 
soaked with 2 mL of the respective hormone solution and samples were taken at the 
same time points as for liquid culture experiments. 
2.2.3.9 Ethanol induction of transgenic lines 
Six-week-old transgenic Arabidopsis plants (short day conditions, vegetative growth 
phase) carrying an ethanol inducible construct and control plants were induced by 
watering with 0.1% (v/v) ethanol. The plants were covered with a transparent lid to 
maintain the ethanol vapour. Rosette leaves for RNA extraction were taken 0, 6, 12 
and 24 hours after induction. 
2.2.3.10 Extraction and measurement of glucosinolates and free auxin 
The original identification of I3M in the transgenic HIG1-1D line is described in 
Schneider et al. (2005) and Gigolashvili et al. (2007). 
For a detailed analysis of the chemotype, glucosinolates were extracted from rosette 
leaves and analysed as described by Gigolashvili et al. (2007). In brief, 
glucosinolates were isolated from methanolic extracts of lyophilised rosette leaves. 
The extracts were loaded to an anion exchange column (DEAE Sephadex A25) for 
purification. After an overnight digestion with sulfatase (E.C. 3.1.6.1; designated ‘type 
H-1, from Helix pomatia, Sigma, D) the deslufo-glucosinolates were eluted from the 
column, vacuum dried and resuspended in a small volume of HPLC grade water for 
subsequent HPLC analysis (performed by C. Müller, University Würzburg). 
Extraction and quantification of free auxin was performed as described by Muller and 
Weiler (2000; quantification was performed by AG Weiler, University Bochum). 
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2.2.3.11 Dual choice assay with Spodoptera exigua (C. Müller, University Würzburg) 
Dual-choice assays were performed to study the consumptional preference of the 
generalist lepidopteran herbivore, Spodoptera exigua (Lepidoptera:Noctuidae). Eggs 
of S. exigua were provided by Bayer CropScience (Monheim, D) and larvae were 
kept on artificial diet. Fourth-instar larvae were used in dual-choice assays. Larvae 
were tested individually in Petri dishes (5.5 cm in diameter) offering them two leaves 
of equivalent age of different Arabidopsis lines on moistened filter paper for 8 h at 
25°C. Leaves were weighed and scanned before and after feeding. Leaf area was 
analyzed using Winfolia (Regent Instruments Inc.). Three different pair combinations 
of leaves were provided to each 20 larvae: HIG1-1D and wild-type (Col-0), HIG1-1D 
and hig1-1, and Col-0 and hig1-1. The consumed fresh weight was calculated by 
[(weight begin*area end)/area begin]. 
2.2.4  Molecular biology methods 
2.2.4.1  Small scale plasmid preparation from E. coli cells (miniprep) 
Small scale plasmid preparations (Miniprep) from E. coli cells were performed with 
the Biorad Quantum Prep® Plasmid Miniprep Kit according to the protocol provided 
by the manufacturer. 
2.2.4.2  Large scale plasmid preparation from E. coli cells 
Large quantities of plasmid DNA were prepared using the QIAGEN Plasmid Midi Kit 
following the manufacturer’s instructions. 
2.2.4.3  Extraction of genomic DNA from plant material (fast prep) 
About 50 mg rosette leaves from Arabidopsis were collected in an Eppendorf tube 
and homogenised in 400 µL extraction buffer (200 mM Tris-HCl, pH 7.5, 250 mM 
NaCl, 25 mM EDTA, 0.5% (w/v) SDS) and mixed on a vortex. The cell debris were 
removed by centrifugation (13000 rpm, 5 min) and the supernatant was mixed with 
350 µL isopropanol. The samples were incubated for 10 min at RT before the DNA 
was pelleted by centrifugation (13000 rpm, 15 min). The pellet was washed once with 
70% (v/v) ethanol, air dried and resuspended in 50 µL TE. 
2.2.4.4  Extraction of total RNA from plant material 
Total RNA used for RT-PCR analysis was extracted from plant tissue using TRIzol® 
reagent (Invitrogen, Karlsruhe) according to the protocol provided by the 
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manufacturer. Total RNA used for microarray hybridisation was isolated according to 
a modified protocol from Chomczynski and Sacchi (1987). The RNA extraction 
solution was prepared as follows. First, a pre-solution was prepared (50% (w/v) 
guanidinium thiocyanate, 0.5% (w/v) sodium laurylsarcosil, 2.5 mM sodium acetate, 
pH 7), which was autoclaved and stored stable for several months. Prior to use the 
pre-solution was mixed 1:1 with phenol (DNA grade, water saturated) and β-
mercaptoethanol was added to 0.35% (v/v) final concentration. The plant material 
(0.3 g) was homogenized with liquid nitrogen in a mortar and the powder was 
resuspended in 2 mL RNA extraction solution. The homogenate was evenly 
distributed to two 2 mL reaction tubes and briefly incubated at RT. Subsequently, 500 
µL of chloroform-isoamyl alcohol (24:1) was added to each tube. The mixture was 
shaken vigorously and left on ice for 30 min, prior to centrifugation (10 min, 12000 g, 
4°C). The upper, aqueous phase was transferred to new tubes and mixed with 1 N 
acetic acid and ethanol at final concentrations of 0.05% (v/v) and 0.7% (v/v), 
respectively. The samples were incubated for 30-60 min on ice and the RNA was 
sedimented by centrifugation (10 min, 14000 g, 4°C). The pellet was resuspended in 
800 µL 3M sodium acetate, pH 5.2, centrifuged (10 min, 14000 g, 4°C) and washed 
twice with 1 mL 80% (v/v) ethanol. The supernatant was removed carefully and the 
pellet was dried under the fume hood for about 15-20 min. The total RNA was 
carefully resuspended in 50 µL DEPC treated water. 
Quantity and quality of the isolated RNA were tested spectrophotometrically at 260 
nm and 280 nm in 50 mM Na2HPO4, pH 7. A ratio of OD260:OD280 between 1.8-2.1 
was considered as pure enough for subsequent cDNA or cRNA synthesis for 
microarray hybridisation. 
2.2.4.5  DNase I treatment and reverse transcription 
To remove any contaminating genomic DNA from isolated total RNA the samples 
were treated with RNase-free DNase I (Roche, Mannheim, D) according to the 
manufacturer’s instructions. About 1-4 µg DNase I treated total RNA were then used 
for reverse transcription, taking on account never exceeding one fourth of the total 
reaction volume. Synthesis of cDNA was performed using SuperScript® II Reverse 
Transcriptase (Invitrogen Life Technologies, Karlsruhe, D) as described in the 
provided protocol and using oligo dT primers (Metabion, Martinsried, D).  
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2.2.4.6  cRNA synthesis and microarray hybridisation 
The Agilent Low RNA Input Fluorescent Linear Amplification Kit was used according 
to the protocol provided for cRNA synthesis and labelling. Hybridisation of the Agilent 
Arabidopsis2 22K microarray v4.1 and processing were performed according to the 
Agilent 60-mer oligo microarray processing protocol. 
2.2.4.7  Polymerase Chain Reaction 
Standard PCR conditions were as follows: 
 25 µL final volume 50 µL final volume 
10x buffer (Qiagen, Stratagene, Biorad) 2.5 µL 5 µL 
50 mM MgCl2 0-1 µL 0-2 µL 
10 mM dNTPs 0.5 µL 1 µL 
10 pmol/µL primer A and B 0.5 µL each 0.5 µL each 
Taq (Qiagen, Stratagene, Biorad) 1 unit 1-2 units 
template DNA 0.5-2 µL 
or a single bacteria 
colony 
0.5-2 µL 
 
HPLC grade water to 25 µL to 50 µL 
 
All PCRs were performed on a MJ Research thermocycler (München, D).  
Standard cycling conditions were: 
cycle number temperature time 
1 94°C 2.5-3 min 
94°C 30 sec 
~5°C<Tm 30 sec 
 
23-32 
72°C 1 min/kb 
1 72°C 10 min 
(Tm indicates the annealing temperature of the primers used) 
2.2.4.8  Yeast Colony PCR 
A single colony was picked and mixed with 25 µL freshly prepared 0.02 N NaOH. The 
cells were lysed for 5 min at RT and 2 µL of the lysate was added to the prepared 
PCR mixture (0.1 mM dNTPs, 10 pmol of primer AD_5N and BD_3N, 1x PCR buffer, 
2.5 mM MgCl2, 1.25 U Taq) with a final volume of 50 µL. The cycling conditions were 
as follows: 94°C (2 min); followed by 40 cycles of 94°C (45 sec) – 50°C (45 sec) – 
72°C (2 min) and a final extension at 72°C (5 min). 
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2.2.4.9  Estimation of quantity and size of DNA fragments 
DNA fragments were separated electrophoretically on 1% (w/v) agarose gels in 1x 
TAE buffer. Size and quantity of DNA fragments was estimated by comparison to the 
1 Kb DNA ladder (Invitrogen Life Technologies, Karlsruhe, D). 
2.2.4.10  Purification of DNA fragments 
DNA fragments were either purified after PCR (QIAquick PCR Purification Kit, Qiagen 
GmbH, Hilden, D) or excised from agarose gels and purified with the QIAquick Gel 
Extraction Kit (Qiagen GmbH, Hilden, D). 
2.2.4.11  Sequencing of DNA fragments 
The sequencing reactions were performed with the Big Dye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems, Foster City, USA) using the following reaction 
conditions: 
DNA 10-100 ng 
5x buffer 1 µL 
Big Dye v3.1 2 µL 
Primer (10pmol/µL) 1 µL 
HPLC grade water to 10 µL 
 
The cycling program was as follows: 
cycle number temperature time 
1 96°C 20 sec 
96°C 10 sec 
55°C 10 sec 
 
35 
60°C 4 min 
 
After termination of the reaction, 10 µL HPLC grade water were added to reach a 
final volume of 20 µL and the samples were processed in the Insitute of Genetics, 
University of Cologne on a ABI 3730 Genetic Analyser (PE Applied Biosystems 
GmbH). The chromatogram files were analysed using the Chromas lite v2.0 software. 
2.2.4.12  Classical vector cloning 
Unless otherwise stated, all classical cloning procedures were performed as 
described by Ausubel et al. (1997). 
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2.2.4.13  Gateway® cloning 
The Gateway® technology is extensively described on the Invitrogen homepage 
(http://www.invitrogen.com/content.cfm?pageid=4072). Furthermore, all kits and 
enzymes used for Gateway® cloning were used according to the manuals provided 
with modifications regarding reaction volume and time. All reactions were performed 
in one fifth of the recommended volume to reduce costs, and the reaction time was 
30 min to 2 h for TOPO reactions and 3 h to overnight incubation for BP and LR 
reactions. 
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3  Results 
3.1  Isolation of the HIG1-1D mutant 
Sequencing of the Arabidopsis genome has revealed that many genes form part of 
gene families. Examples are transcriptional regulators that, unlike in animals, belong 
to large families in A. thaliana. Studying the function of these genes by classical 
knock-out screenings is often limited due to a high functional redundancy. One way 
to overcome this problem is the use of dominant mutants, such as activation-tagging 
populations. An artificial transcriptional enhancer (activation-tag) is integrated 
randomly into the genome as transfer DNA (T-DNA). Integration of the activation-tag 
in close proximity of a gene can result in the transcriptional upregulation, thereby 
generating a dominant overexpression line. Several activation-tagging populations 
have been described, and they have been used successfully to assign functions to so 
far uncharacterised genes (Weigel et al., 2000; Borevitz et al., 2000). One of these 
populations is the TAMARA collection, which was employed in a high-through put 
HPLC screen to identify mutants with an altered secondary metabolite profile 
(Schneider et al., 2005). Rosette leaves of T1 generation plants grown in the 
greenhouse were used for the preparation of methanolic extracts and analysis by 
HPLC according to Reichelt et al. (2002). One of these lines, line 19.4, showed a 
significant upregulation of a single compound (Fig. 3.1), eluated at 13.8 minutes 
retention time under the chosen conditions (Schneider et al., 2005). Preparative 
Figure 3.1: HPLC profile of rosette leaf extracts taken from wild-type (Col-0) and the 
activation-tagging line 19.4. The peak at 13.8 minutes retention time is clearly increased in
the activation-tagging line and was identified as indol-3-ylmethyl glucosinolate. 
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HPLC analysis in combination with mass spectrometry allowed the identification of 
the compound as indol-3-ylmethyl glucosinolate (I3M; all biochemical analysis were 
performed by H.-P. Mock, Gatersleben). 
The observed accumulation of I3M was stable over four generations and the mutation 
was shown to be dominant by backcrossing with wild-type. The mutant was therefore 
called HIG1-1D for High Indolic Glucosinolate 1 – 1 Dominant and was chosen for 
subsequent detailed analysis. 
Since the mutation was generated by T-DNA integration, the site of integration could 
be identified by TAIL-PCR (performed by T.Gigolashvili, University of Cologne; 
Schneider et al., 2005) and was localised on chromosome 1, about 1.4 kb upstream 
of the At1g18570 locus. To confirm the gene-to-trait relation between the presence of 
the activation-tagging element and the accumulation of I3M, a segregating F2 
population generated by backcrossing to wild-type, was analysed. The genotype of 
the F2 individuals was verified by PCR and HPLC analyses were performed to 
quantify the amount of I3M (Fig. 3.2). Plants carrying the activation-tagging element 
showed an up to 4-fold accumulation of I3M when compared to wild-type plants. 
Plants heterozygous for the activation-tag showed slightly less accumulation than 
homozygous HIG1-1D plants, indicating that the I3M accumulation might be dosage 
dependent. 
 
Figure 3.2: Relative I3M concentration of a segregating F2 population. Plants heterozygous 
and homozygous for HIG1-1D showed up to 4-fold increase in I3M accumulation compared 
to wild-type plants (mean ±SD; n=10). 
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3.2  HIG1 encodes an R2R3 MYB transcription factor 
To identify the cause of high I3M accumulation in the HIG1-1D mutant, the candidate 
genes, surrounding the activation-tag insertion were analysed, since overexpressed 
genes are often found adjacent to the inserted enhancer (Weigel et al., 2000). The 
transcript profiles of two genes upstream and three genes downstream of the 
insertion were analysed by semi-quantitative RT-PCR (T.Gigolashvili, University of 
Cologne). Only the transcript of At1g18570 was significantly upregulated in the HIG1-
1D mutant, compared to the wild-type control (Fig. 3.3). The transcript of At1g18550 
(kinesin motor protein-related) was unchanged, transcription of At1g18560 
(transposase-related protein) could not be detected, neither in HIG1-1D nor in wild-
type plants. The expression level of At1g18580 (putative galacturonosyl transferase; 
Sterling et al., 2006) and At1g18590 (sulfotransferase AtST5c; Piotrowski et al., 
2004; Klein et al., 2006) were comparable in the wild-type and the mutant line. 
Therefore, the overexpression of At1g18570 appeared to be the cause for I3M 
accumulation in the HIG1-1D mutant.  
At1g18570 encodes for an R2R3-type MYB transcriptional regulator, classified as 
MYB51 (Stracke et al., 2001). MYB51 is a member of the subgroup 12 of R2R3 MYB 
factors that share the common motif [L/F]NK[K/R]VA in the carboxy-terminal region 
(Fig. 3.4). There are five additional members in subgroup 12, with MYB122 being the 
closest homologue. ATR1/MYB34 has been previously characterised as a regulator 
of tryptophan biosynthesis (Bender and Fink, 1998) and was shown to play a role in 
the auxin-glucosinolate homeostasis (Celenza et al., 2005). The other members are 
currently under investigaton. 
Figure 3.3: Schematic representation of the T-DNA integration site of HIG1-1D on 
chromosome I. The transcript of the indicated loci were analysed by RT-PCR. Only the 
transcript of At1g18570 was altered in comparison to the wild-type level. Actin2 was used as 
control. 
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The gene structure of HIG1/MYB51 consists of 3 exons and two introns, encoding a 
protein of 352 amino acids (aa) with a calculated mass of 39 kDa and an isoelectric 
point (pI) of 5.6. The two MYB domains are located at the amino-terminal region of 
the protein (R2:aa 9-62; R3: aa 63-113), while the motif specific for subgroup 12 is 
located in the middle of the sequence (aa 174-179). 
3.3  HIG1/MYB51 is nuclear-localised 
Several programs that predict the subcellular localisation of proteins are available 
online. Examples are  the servers of WoLF PSORT (http://wolfpsort.org/; Horton et 
al., 2006) or LOCtree (http://cubic.bioc.columbia.edu/services/loctree/; Nair and Rost, 
2005). Both software systems predict HIG1/MYB51 to be nuclear-localised, 
consistent with the idea of a transcriptional regulator. To confirm the in silico 
prediction, the subcellular localisation was tested in vivo. The full-length coding 
sequence of HIG1/MYB51 was cloned into pGWB5 for translational fusion with the 
green fluorescent protein (GFP) under control of the CaMV 35S promoter. Whereas 
transfection of tobacco BY2 protoblasts with the empty pGWB5 vector resulted in a 
Figure 3.4: (A) Phylogenetic tree of subgroup 12 R2R3 MYB transcription factors in relation 
to MYB GL1. (B) Schematic representation of the protein structure. R2 and R3 indicate the
two MYB domains at the amino-terminal end. 12 indicates the common motif
[L/F]NK[K/R]VA with unknown function. 
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disperse GFP staining, the HIG1/MYB51-GFP fusion protein was clearly detectable in 
nuclei of transfected cells (Fig. 3.5), confirming the sequence based prediction. The 
DNA specific DAPI staining was used as a nuclear staining control. 
3.4  HIG1/MYB51 is mainly expressed in vegetative organs 
To get a general idea about the expression pattern of HIG1/MYB51, samples from 
different organs of A. thaliana wild-type plants in the reproductive growth phase were 
taken for RT-PCR analysis. Transcription of HIG1/MYB51 could be detected in the 
roots and rosette leaves of 6-week-old plants (Fig. 3.6). Furthermore, HIG1/MYB51 
could be amplified from cDNA synthesised from stem samples. However, 
HIG1/MYB51 transcription was not detectable in mature siliques or flowers. 
Therefore, the expression of HIG1/MYB51 is restricted to vegetative organs of A. 
thaliana, and is not found in reproductive organs.  
In order to study in more detail the expression of the gene, the promoter activity of 
HIG1/MYB51 was analysed using the GUS reporter system. A 2 kb fragment, 
including 1.6 kb upstream the start codon, as well as the first exon, first intron and 
Figure 3.6: RT-PCR analysis from different organs of 6-week-old A. thaliana wild-type 
plants. R=roots, L=rosette leaves, St=stem, Si=mature silique, F=mature flowers. Gene
specific primers were used for HIG1/MYB51 and Actin2, as positive control. 
Figure 3.5: Subcellular localisation of the HIG1/MYB51-GFP fusion protein in tobacco BY2 
protoplasts. (A) HIG1/MYB51-GFP signal; (B) DNA specific DAPI staining; (C) empty vector
control. 
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part of the second exon (-1676 to +342 bp) was amplified from genomic DNA and 
cloned into pGWB3 for translational fusion with the GUS reporter protein. More than 
twenty independent transgenic A. thaliana lines carrying the ProHIG1/MYB51-GUS 
construct were analysed. Twelve lines showing a qualitatively similar expression 
pattern were chosen for more detailed histochemical studies (Fig. 3.7). Reporter 
gene activity could be observed in the hypocotyl of 3-day-old seedlings (Fig. 3.7A). 
GUS expression was undetectable in the cotyledons at this stage, but appeared in 
the cotyledons of 7-day-old seedlings (Fig. 3.7B). New emerging rosette leaves did 
not show activity of the HIG1/MYB51 promoter (Fig. 3.7C,D). However, expanding 
rosette leaves showed blue GUS staining around the mid vein and in the trichome 
pavement cells (Fig. 3.7D,E). Trichomes themselves also expressed the GUS 
reporter. In fully expanded rosette leaves, blue GUS staining was additionally 
detectable in the mesophyll, indicating HIG1/MYB51 expression in the complete 
rosette leaf at the fully expanded stage (Fig. 3.7F).  
Furthermore, as indicated by the RT-PCR analysis, HIG1/MYB51 promoter activity 
was detectable in roots, mainly in the differentiation zone close to the root tip, but 
Figure 3.7: Histochemical GUS staining of ProHIG1/MYB51-GUS plants. (A) 3-day and (B) 7-day 
old seedling; (C) young and (D) mature rosette; (E) young rosette leaf; (F) fully expanded
rosette leaf; (G) main and lateral root; (H) young and (I) mature flower; (J) young and mature
silique. 
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also to a lesser extend in the vasculature of mature roots (Fig. 3.7G). Reproductive 
organs like flowers and siliques showed GUS activity only at an early stage of 
development. Young flowers showed faint expression in the vasculature of sepals 
(Fig. 3.7H). GUS expression was absent in mature flowers (Fig. 3.7I), coherent with 
the results obtained by RT-PCR. In young siliques, reporter gene activity was 
detectable at the stigma and the abscission zone. Mature siliques did not show any 
GUS activity (Fig. 3.7J). Summarising, expression of HIG1/MYB51 was mainly 
detected in vegetative organs, while in reproductive organs it was observed only at 
an early stage of development. These results are in agreement with additional gene 
expression data available at Genevestigator (www.genevestigator.ethz.ch; 
Zimmermann et al., 2004b). 
3.5  HIG1/MYB51 overexpression leads to a high glucosinolate 
profile 
The initial HPLC analysis showed an increased I3M content in the HIG1-1D mutant 
line. I3M is the main indolic glucosinolate present in A. thaliana and it was interesting 
to find out, whether other glucosinolates were also affected by HIG1/MYB51 
misexpression. Therefore, HIG1/MYB51 overexpression lines and a knock-out line, 
together with HIG1-1D were analysed in more detail in collaboration with C. Müller 
(University Würzburg). The knock-out line was isolated from the GABI-Kat collection. 
The line 228B12 carries a T-DNA insertion in the second exon of HIG1/MYB51, 
thereby generating a transcriptional knock-out as revealed by RT-PCR (Fig. 3.8). The 
line is therefore referred to as hig1-1. Overexpression lines were generated by 
introducing the complete coding sequence of HIG1/MYB51 into pGWB2 for ectopic 
overexpression under control of the CaMV 35S promoter. Three independent lines 
with a stable overexpression up to the T3 generation were chosen for biochemical 
analysis. 
Figure 3.8: RT-PCR analysis of samples taken from wild-type (Col-0), knock-out (hig1-1), 
three independent overexpression lines (35S:HIG1-1,3,7) and the activation-tagging mutant 
(HIG1-1D). 
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The glucosinolate profile of rosette leaves showed a significantly increased I3M 
content not only in the original activation-tagged line HIG1-1D, but also in the three 
lines with ectopic overexpression of HIG1/MYB51 (Fig. 3.9). This indicates that the 
overexpression is sufficient to generate a high indolic glucosinolate chemotype, 
irrespective of the genomic environment. The increase in I3M was up to 9-fold higher 
in the mutant lines compared to the wild-type background. In contrast, the hig1-1 
knock-out mutant accumulated only half the amount of I3M compared to wild-type 
plants. Apart from the increased I3M content in the overexpressors, the content of 
two minor indolic glucosinolates was also affected. Both 4MOI3M and 1MOI3M were 
significantly increased in at least three overexpression lines (35S:HIG1-7, 35S:HIG1-
8, HIG1-1D). Interestingly, the upregulation of indolic glucosinolates was 
accompanied by a down regulation of the major aliphatic glucosinolate 4MSOB. 
Nevertheless, the total amount of measured glucosinolates (indolic and aliphatic) in 
the HIG1/MYB51 overexpression lines was about twice the amount in wild-type 
samples. The total glucosinolate concentration in hig1-1 was reduced by half when 
Figure 3.9: Glucosinolate (GS) content of wild-type and transgenic lines extracted from 
freeze dried rosette leaves of 5-week old plants grown under short day conditions 
(vegetative growth phase). 3MSOP, 3-methylsulfinylpropyl-GS; 4MSOB, 4-
methylsulfinylbutyl-GS; 5MSOP, 5-methylsulfinylpentyl-GS; 8MSOO, 8-methylsulfinyloctyl-
GS; I3M, indol-3-yl-methyl-GS; 4MOI3M, 4-methoxyindol-3-ylmethyl-GS and 1MOI3M, 1-
methoxyindol-3-ylmethyl-GS. Asterisks denote significant difference in comparison to wild-
type (mean ±SD; n=3; Student’s t-test; P<0.05). 
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compared to the Col-0 wild-type background. Surprisingly, 4MSOB was also reduced 
in the knock-out mutant. However, the ratio of aliphatic to indolic glucosinolates 
changed only slightly in hig1-1 (ratio of aliphatic/indolic glucosinolates (a/i): 2.5) with 
respect to the observed wild-type ratio (a/i: 2.2). In contrast, the homeostasis 
between aliphatic and indolic glucosinolates appeared to be altered in the lines 
overexpressing HIG1/MYB51. Here, the high content of indolic glucosinolates 
decreased the ratio to 0.5 and less. Taken together, overexpression of HIG1/MYB51 
influenced the accumulation of both indolic and aliphatic glucosinolates. 
3.6  HIG1/MYB51 overexpression does not alter the growth 
phenotype 
The tight link of the indolic glucosinolates and IAA pathway often results in an altered 
IAA accumulation upon alteration of indolic glucosinolate biosynthesis (section 1.2). 
Unlike previously described glucosinolate mutants, no characteristic auxin phenotype 
was observed in HIG1-1D or hig1-1. Both lines were indistinguishable from wild-type 
plants throughout the life cycle under the tested growth conditions. Analysis of the 
endogenous IAA level revealed a slight increase in HIG1-1D compared to the wild-
type level, whereas the IAA concentration in the hig1-1 knock out was reduced, 
compared to wild-type plants (Fig. 3.10). However, these changes in the IAA level 
were minor compared to the effect of overexpressing the close homologue 
ATR1/MYB34. Some lines with ectopic overexpression of ATR1/MYB34 under control 
of the CaMV 35S promoter showed drastically elevated IAA concentrations (one line 
is shown in Fig. 3.10) reflected in a high auxin growth phenotype with stunted plants 
and malformed flowers (Gigolashvili et al., 2007). 
Figure 3.10: Free IAA content in 
rosette leaves of the indicated 
lines (mean ±SD; n=3). The 
overexpressor of ATR1/MYB34
(35S:ATR1-17) was described by 
Gigolashvili et al., 2007. Plants 
were grown under short day 
conditions. 
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A key enzyme in the auxin-glucosinolate homeostasis appears to be anthranilate 
synthase (section 1.2), which is also activated upon ethylene induced auxin 
biosynthesis (Stepanova et al., 2005) and influenced by ATR1/MYB34 (Bender and 
Fink, 1998; Celenza et al., 2005). To test, whether the slight increase in IAA in the 
HIG1-1D mutant was mirrored by altered anthranilate synthase regulation, the 
response to the toxic tryptophan analogue, 5-methyl tryptophan (5MT) was 
investigated. Constitutive activation of anthranilate synthase by ATR1/MYB34 
overexpression overcomes the negative feedback regulation by 5MT and ensures a 
sufficient tryptophan synthesis, reflected by an increased resistance to 5MT (Bender 
and Fink, 1998). Conversely, HIG1-1D did not show an altered 5MT tolerance 
compared to wild-type plants when grown on 5MT supplemented media. Wild-type, 
hig1-1 and HIG1-1D seedlings all displayed the same reduced root growth on media 
containing 15 µM 5MT (Fig. 3.11). However, the transgenic line 35S:ATR1-17, 
overexpressing ATR1/MYB34, showed a significantly better root growth on 5MT 
containing medium, reflecting an altered regulation of anthranilate synthase. Unlike 
ATR1MYB34, HIG1/MYB51 did not seem to affect the feedback inhibition of 
anthranilate synthase and had only little influence on the IAA concentration. 
Figure 3.11: Growth phenotype on media containing 5-methyl tryptophan (5MT) of wild-type 
(Col-0), hig1-1 knock-out, HIG1-1D and an ATR1/MYB34 overexpression line (35S:ATR1-
17; Gigolashvili et al., 2007).  The seedlings were grown for 10 days on germination medium
containing 0 µM and 15µM 5MT. (A) representative picture of 10-day old seedlings, the 
white scale bar indicates 1 cm;  
(B) mean root length of 10-day old seedlings (mean ±SD; n=10). 
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3.7  HIG1/MYB51 overexpression activates indolic glucosinolate 
pathway genes 
Overexpression of HIG1/MYB51 resulted in an accumulation of indolic glucosinolates 
and a decrease of 4MSOB. Consequently, the question arises, whether HIG1/MYB51 
controls the expression of glucosinolate pathway genes. The same lines used for the 
biochemical characterisation were therefore used for expression studies by RT-PCR. 
The transcript levels of genes involved in the tryptophan synthesis, as well as those 
downstream of tryptophan participationg in the formation of I3M, were analysed. In 
addition, expression analyses of genes coding for key enzymes in the aliphatic 
glucosinolate biosynthesis were performed (pathway is given in Fig. 1.1). Studying 
the HIG1/MYB51 overexpression lines, the most striking upregulation in gene 
expression were observed for CYP79B2/B3 and CYP83B1, the enzymes responsible 
for the first steps in indolic glucosinolate biosynthesis (Fig. 3.12). However, the genes 
coding for enzymes further downstream the biosynthesis pathway were also 
upregulated, like UGT74B1 and AtST5a. This reflects the increased accumulation of 
Figure 3.12: RT-PCR analysis of glucosinolate pathway genes. DHS1, DAHP synthase 1; 
ASA1, anthranylate synthase alpha 1; TSB1, tryptophan synthase beta 1; CYP, cytochrome
P450 monooxygenase; UGT, S-glucosyltransferase; AtST, A. thaliana sulfotransferase. 
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I3M in these lines. In addition, the structural genes further upstream in the pathway 
were also slightly affected, with a moderate increase in DHS1 and TSB1 transcription 
in the HIG1/MYB51 overexpressors compared to the wild-type and hig1-1 mutant. 
Transcription of ASA1 appeared unchanged, which reflects the observed sensitivity 
to 5MT. In contrast, transcription of CYP79F1/F2 and CYP79A1, encoding the key 
enzymes of aliphatic glucosinolate biosynthesis, were downregulated in HIG1-1D and 
the other overexpression lines, in accordance with the decreased accumulation of the 
main aliphatic glucosinolates 4MSOB observed in these transgenic lines.  
However, transcript profiling in transgenic lines with constitutive overexpression of 
HIG1/MYB51 might reflect secondary adaptations to the constitutive overexpression, 
rather than a direct response. Therefore, an alternative approach was used to 
investigate the complete transcript pattern in response to HIG1/MYB51 activation, 
which also aimed at finding further putative target genes. The complete coding 
sequence of HIG1/MYB51 was introduced into the ethanol inducible expression 
system described by Caddick et al. (1998). More than 20 independent transgenic 
lines, carrying the ethanol inducible MYB51/HIG, were generated in the hig1-1 
background. One homozygous T3 line, displaying high HIG1/MYB51 transcription 
after ethanol induction and a 3:1 segregation ratio in the T2, indicative of a single 
insert, was chosen for microarray analysis. Rosette leaves were taken for RNA 
extraction 24 hours after ethanol induction (plants were irrigated with 0.1% (v/v) 
ethanol) and compared to samples taken at the zero time point. Synthesised 
complementary RNA (cRNA) of both samples was labelled with Cy5 and Cy3, 
resulting in four fluorescently labelled cRNA pools (0h-Cy5, 0h-Cy3, 24h-Cy5, 24h-
Cy3). Two Agilent 22K chips were hybridised with cRNA of both time points but 
differently labelled (Chip 1: 0h-Cy5, 24h-Cy3; Chip 2: 0h-Cy3, 24h-Cy5), using the 
dye swap between the two chips as an internal control. The raw data was processed 
with the provided Agilent Feature Extraction Software v.7.1 and transcripts, which 
met the following criteria: significant increase/decrease (p-value<0.05), signal well 
above background and greater than twofold change in both hybridisations; were 
considered significantly altered after ethanol induction of HIG1/MYB51. In total, 893 
transcripts fulfilled these criteria, 429 being upregulated and 464 being 
downregulated after 24 hours HIG1/MYB51 induction. For further analysis of the 
genes with altered expression, the MapMan software v.2.0.0 was used (Thimm et al., 
2004), which allows assigning the transcripts to functional classes and a graphical 
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Figure 3.13: Scheme of the indolic glucosinolate biosynthesis with the branches to auxin
and camalexin. The genes that are upregulated after 24 hours MYB51/HIG1 induction are 
indicated in bold with the respective log10 ratio given in parenthesis. DHS1, DAHP synthase 
1; ASA1, anthranilate synthase alpha 1; ASB1, anthranilate synthase beta 1; IGPS, indole-
3-glycerolphosphate synthase; TSB1, tryptophan synthase beta 1; CYP, cytochrome P450
monooxygenase, GST, gluthatione-S-transferase, UGT, S-glycosyltransferase; AtST, A. 
thaliana sulfotransferase; NIT, nitrilase; IAN, indole-3-acetonitrile. 
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display of various pathways. Since the RT-PCR analyses indicated a regulation of the 
indolic glucosinolate biosynthesis genes by HIG1/MYB51, it was interesting to see 
whether these genes are also affected by a transient induction of HIG1/MYB51. 
Furthermore, the effect on other described biosynthesis pathways was investigated 
using the MapMan software. However, none of the incorporated pathways appeared 
to be affected at the level of multiple genes, besides the indolic glucosinolate 
biosynthesis pathway and its branches. The genes upregulated by HIG1/MYB51 
induction in the glucosinolate pathway and their expression ratio (log10) are 
represented in Figure 3.13. As seen from the constitutive HIG1/MYB51 
overexpression lines, the genes coding for enzymes downstream IAOx were 
upregulated (CYP83B1, UGT74B1, AtST5a) with the exception of C-S lyase. 
Moreover, there was an activation of ASB1 and IGPS, both acting upstream of 
tryptophan biosynthesis. Interestingly, only ASB1 was activated but not ASA1, 
encoding the feedback regulated subunit of anthranilate synthase. Apart from genes 
involved in the synthesis of tryptophan and indolic glucosinolates, also the branching 
pathway of camalexin biosynthesis appeared to be induced, since CYP71B15 
transcription was highly upregulated. Furthermore, NITRILASE2 (NIT2) was activated 
in plants subjected to ethanol induced HIG1/MYB51 expression, which codes for the 
enzyme catalyzing the conversion of indol-3-acetonitrile (IAN) to IAA. In addition, 
several GSTs were upregulated. It has been speculated whether GSTs are involved 
in glucosinolate biosynthesis (Halkier and Gershenzon, 2006), but no GST could be 
directly assigned to that pathway so far. The GSTs upregulated by HIG1/MYB51 
induction might therefore be candidates, three of them being under the top 25 
induced genes (Tab. 3.1; Fig. 3.13). Taken together, the upregulation of indolic 
glucosinolate pathway genes, observed in constitutive HIG1/MYB51 overexpression 
lines could be confirmed after transient induction of HIG1/MYB51. Besides a putative 
upregulation of the pathways related to indolic glucosinolate biosynthesis, no further 
biosynthesis pathways could be identified as targets of HIG1/MYB51 regulation. 
Looking at the strongest induced genes after HIG1/MYB51 induction, one can find 
members of large enzyme families, like GSTs, cytochrome P450 monooxygenases 
(CYPs) and UDP-glucosyl transferases (Tab. 3.1). Furthermore, biotic stress 
response genes were induced, like avirulence induced gene 1 (AIG1) and a putative 
disease resistance protein. Interestingly, MYB4, a repressor of phenylpropanoid 
biosynthesis (Jin et al., 2000; Hemm et al., 2001) was also upregulated. 
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In addition to the examination of single genes, the MapMan software allows to 
investigate the alteration of complete functional classes (Tab. 3.2). A significant 
upregulation of genes involved in protein biosynthesis was observed, but also genes 
for DNA and chromatin modelling were activated. This suggests an increased 
demand for the transcriptional and translational machinery after ethanol induction, 
with so many genes being up- and downregulated. Apart from protein synthesis, two 
further functional classes were induced, GSTs and heat induced genes, mainly heat 
shock proteins. Both could be a general stress response of the plant, due to the 
experimental set up. However, the upregulation of GSTs could also be a direct 
response to HIG1/MYB51 induction. Apart from functional classes that are 
significantly induced, there was also one class being downregulated. In total, 
transcription of 50 genes involved in hormone metabolism was changed, with the 
majority being downregulated. More specifically, a significant impact on auxin-
responsive genes (e.g. IAA2, IAA3, IAA6, IAA19) and genes involved in ethylene 
signalling was observed.  
Table 3.2: Functional classification of genes with significantly changed expression after 
MYB51/HIG1 induction. The analysis was based on the Wilcoxon Rank Sum Test 
(Benjamini-Hochberg corrected), included in the MapMan software. 
 
functional class 
# 
deregulated 
genes 
direction of 
deregulation 
p-value 
(Benjamini-
Hochberg 
corrected) 
protein 164 ↑ 1,61E-13
     protein.synthesis 108 ↑ <0,00E-20
        protein.synthesis.misc ribososomal protein 102 ↑ <0,00E-20
hormone metabolism 50 ↓ 1,22E-03
         hormone metabolism.auxin.induced-regulated- 
responsive-activated 
14 ↓ 5,20E-02
        hormone metabolism.ethylene.signal 
transduction 
10 ↓ 6,85E-02
misc.glutathione S transferases 9 ↑ 1,88E-03
stress.abiotic.heat 20 ↑ 1,86E-02
DNA.synthesis/chromatin structure 15 ↑ 2,73E-02
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3.8  HIG1/MYB51 activates promoters of indolic glucosinolate 
 pathway genes 
Analyses of the transcriptional profiles in constitutive and induced HIG1/MYB51 
overexpression lines suggest an induction of indolic glucosinolate pathway genes by 
HIG1/MYB51. To test the ability of HIG1/MYB51 as a transcriptional activator, a 
transient expression system in cultured A. thaliana cells was employed. The system 
takes advantage of a hypervirulent A. tumefaciens strain yielding high transformation 
rates (van de Fits et al., 2000). Transformation is achieved by simply mixing the plant 
cells with the agrobacteria carrying the desired constructs. Effector constructs 
express the transcriptional regulator under control of a constitutive promoter, the 
reporter constructs are generated by introducing the putative target promoter in front 
of an intron-tagged uidA ORF. The system was validated previously with described 
transcription factor/promoter interactions of the phenylpropanoid pathway (Berger et 
al., 2007). 
Here, the potential of HIG1/MYB51 to activate the promoters of seven different indolic 
glucosinolate pathway genes was tested. Therefore, the overexpression construct of 
HIG1/MYB51 in pGWB2 (see section 3.5) was used as an effector construct. The 
reporter constructs were generated by cloning the promoters of three genes 
upstream tryptophan synthesis (DHS1, ASA1, TSB1) and those of four genes 
downstream tryptophan synthesis (CYP79B2, CYP79B3, CYP83B1, AtSt5a) into 
pGWB3i, for promoter driven GUS expression (clones were generated by 
R. Yatusevich, T. Gigolashvili, B. Kleinhenz, University of Cologne, and are described 
in Gigolashvili et al., 2007). Transformation of A. thaliana cells with the reporter 
constructs alone revealed a moderate background activity of the DHS1, CYP83B1 
and AtSt5a promoters, as indicated by the measured GUS activity (Fig.3.14B). This 
was also seen by the histochemical GUS staining of cells transfected with the DHS1 
and AtST5a reporter constructs (Fig. 3.14A). The promoters of ASA1, TSB1, 
CYP79B2 and CYP79B3 did not drive GUS expression when transformed into the 
cell culture alone. Cotransformation with the HIG1/MYB51 effector resulted in a 
significant induction of all tested promoters, except for the promoter of ASA1. The 
strongest activation was observed for the promoter of DHS1 and AtSt5a, but also the 
promoters of TSB1, CYP79B2, CYP79B3 and CYP83B1 were significantly induced 
by HIG1/MYB51. As seen by transcriptional profiling and growth on 5MT, 
HIG1/MYB51 does not appear to activate ASA1. However, HIG1/MYB51 is able to 
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induce the other tested promoters of the indolic glucosinolate pathway genes, further 
validating the idea of it being a transcriptional regulator. 
Figure 3.14: GUS activity of reporter constructs in transiently transformed A. thaliana cells 
cotransformed with or without the 35S:HIG1 effector. (A) Histochemical GUS staining of
transformed cells; (B) Quantitative measurment of the GUS activity. Values are given as the
formation of 4-methylumbelliferone (4MU) per min and mg protein (mean ±SD; n=4). 
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3.9  HIG1/MYB51 expression is mechano-sensitive 
The results presented so far, suggest a role of HIG1/MYB51 as a regulator of 
glucosinolate biosynthesis. Since glucosinolates are a major component of the plant 
defence against herbivore attack and are known to be induced by wounding or 
hormone treatment, the question arises, whether HIG1/MYB51 is involved in one of 
these signalling pathways. Therefore, the response of HIG1/MYB51 to mechanical 
stimuli and hormone treatment was tested. RT-PCR analysis of punctured rosette 
leaves showed an induction of HIG1/MYB51 expression already 15 minutes after 
wounding (Fig.3.15). HIG1/MYB51 transcript levels were highest 30 minutes after 
wounding and were already back to control level in samples taken after two hours. 
This strongly indicates a transient induction of HIG1/MYB51 expression after 
wounding. In a second attempt for testing the mechano-sensitive induction of 
HIG1/MYB51, the GUS reporter lines (see section 3.4) were employed. It could be 
Figure 3.16: Histochemical GUS staining of ProHIG1/MYB51-GUS rosette leaves. (A) 
unwounded leaf, detached after staining; (B) leaf with cutting site; (C, D) leaves that were
pressed between two fingers. 
Figure 3.15: RT-PCR analysis of samples taken from punctured rosette leaves 0, 15, 30
and 120 minutes after wounding. 6-week-old wild-type plants were grown under short day 
conditions and punctured with a whole puncher. Actin2 was used as a control. 
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seen that HIG1/MYB51 promoter driven GUS expression was more pronounced at 
sites of cutting than in unwounded tissues (Fig. 3.16B). Also pressing of rosette 
leaves between two fingers resulted in an activation of the reporter construct 
(Fig. 3.16C,D).  
Since wounding and herbivore attack are often accompanied by the activation of 
hormone signalling pathways, the responsiveness of HIG1/MYB51 to one of the 
major stress signalling hormones was tested. The expression was analysed in 
response to methyl jasmonate (MeJA), salicylic acid (SA) and the ethylene precursor 
1-aminocyclopropane-1-carboxylic acid (ACC). For this purpose, wild-type 
Arabidopsis plants were sprayed with aqueous solutions containing the respective 
hormones and samples were taken for RT-PCR analysis (Fig. 3.17). An induction of 
HIG1/MYB51 could be observed 30 minutes after spraying in all treatments, including 
the mock treatment. The transcript level decreased two and four hours after spraying, 
resembling the observed effect after wounding. Consequently, the mechanical 
stimulus of spraying appears to be sufficient to trigger an upregulation of 
HIG1/MYB51. Since the mechano-sensitivity of HIG1/MYB51 makes it impossible to 
study hormone activation by spraying plants, different attempts presented in section 
3.10 were used to overcome this problem. 
3.10  Ethylene activates the HIG1/MYB51 promoter in root tips 
One attempt to study a possible hormone response of HIG1/MYB51 was to grow the 
ProHIG1/MYB51-GUS lines on hormone supplemented media. However, growth and 
morphology of the seedlings were drastically affected by the chosen hormone 
concentrations. Conclusions about specific hormone effects were not clear. Growing 
plants on normal germination media with a later transfer to hormone supplemented 
Figure 3.17: RT-PCR analysis of rosette leaves sprayed with no hormone (mock), SA (0.5
mM), MeJA (0.45 mM) or ACC (10 µM) in 0.1% (v/v) ethanol, 0.01% (v/v) Tween. Samples
were taken 0, 0.5, 2 and 4 hours after spraying. 
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plates was not feasible, because the mechanical stress during transfer would have 
interfered with the possible hormone response. Therefore, the GUS reporter lines 
were grown on solid germination media covered with a sterile filter paper, allowing 
the roots of the seedlings to grow on top. This provided the possibility of a later 
induction with hormones by applying the respective solution to the filter paper, 
without damaging the seedlings themselves. For the initial spraying experiments 
relatively high hormone concentrations of SA and MeJA were used as described in 
previous studies (SA: 0.5 mM; MeJA: 0.45 mM; Cipollini et al., 2004). However, 
experiments with seedlings grown in liquid culture showed that these concentrations 
might be too high when applied directly to the root system. When SA was added to a 
final concentration of 0.5 mM, the seedlings died within 12 hours. Hence, all 
hormones were applied at 10 µM, the same concentration used for the 
AtGenExpress experiments. Hormone solutions of SA, MeJA and ACC were applied 
to the roots of 3-week-old ProHIG1/MYB51-GUS reporter lines and whole plants were 
fixed and stained for GUS activity 4, 24 and 48 hours after hormone treatment, 
Figure 3.18: Histochemical GUS staining in roots of ProMYB51/HIG1-GUS lines after hormone 
treatment. An overview an a close-up of the root tip is displayed. Plants were grown
vertically on solid germination medium covered with filter paper. For hormone treatment the
filter was soaked with 2 mL of hormone solution (each 10 µM in 0.01% (v/v) ethanol) and the 
samples were taken at the indicated time points for GUS staining. 
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respectively. The GUS staining pattern observed in the rosettes of all tested 
seedlings was unchanged compared to the control samples with increased staining in 
expanded leaves as described in section 3.4. Looking at the root system, GUS 
activity was absent in the meristematic and elongation zone of control samples 
(Fig. 3.18). Occasionally the root cap displayed light blue GUS staining. However, 
HIG1/MYB51 promoter driven GUS expression was detectable in the differentiation 
zone. The same pattern was observed for plants treated with MeJA and SA, at all 
tested time points. Application of ACC to the reporter plants led to an altered GUS 
expression pattern. After 4 hours, strong GUS activity was detectable in the 
elongation zone. Samples taken 24 and 48 hours after ACC treatment displayed an 
increased number of elongated root hairs, the described effect of ACC on root growth 
and morphology. GUS staining in these samples was intense in the complete root tip, 
also in the meristematic region. However, highest activity was seen in the 
differentiation zone with strong stained root hairs. Taken together, the tested 
hormones did not appear to influence HIG1/MYB51 in the green part of the plants. 
The only observable effect was seen in root tips, where ACC led to a strong induction 
of the ProHIG1/MYB51-GUS reporter. Hence, HIG1/MYB51 appears to be regulated site 
specifically by the ethylene precursor ACC. 
3.11  Overexpression of HIG1/MYB51 leads to increased 
resistance against a generalist herbivore 
Glucosinolates, together with myrosinase, present a well characterised defence 
system against herbivores (section 1.3). Since HIG1-1D showed an increased 
content in total glucosinolates, mainly due to the high I3M concentration, the effect on 
herbivore consumption was analysed. For this purpose, the feeding preference of the 
generalist herbivore Spodoptera exigua (Lepidoptera) was tested in a dual choice 
assay (in collaboration with C. Müller, University Würzburg). Fourth-instar larvea of 
S. exigua were kept on artifical diet before being offered two rosette leaves of the 
same age, but originating from different plant lines (Fig. 3.19A). The larvae were 
placed in a Petri dish with the two leaves on moistened filter paper and allowed to 
feed for 8 hours. Afterwards, the consumed leaf weight was calculated according to 
the consumed leaf area. When offered Col-0 and hig1-1 leaves at the same time, 
there was no significant feeding preference (Fig. 3.19B). The same amount of both 
leaves was consumed by the larvae. However, there was a remarkable difference in 
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the consumed leaf weight when leaves of HIG1-1D were offered. In these cases, 
there was an increased consumption of the alternative leaf, irrespective whether Col-
0 or hig1-1 was offered as alternative. This clearly indicates that the upregulation of 
HIG1/MYB51 along with the accumulation of indolic glucosinolates leads to an 
increased resistance of HIG1-1D plants against the generalist S. exigua.  
3.12  Screening for proteins interacting with HIG1/MYB51 
It is known from other transcriptional regulators that they often act in concert with 
other transcription factors. For instance, the interaction between MYB factors and 
basic helix-loop-helix (bHLH) proteins has been well characterised (Zimmermann et 
al., 2004a). Furthermore, it is known that transcription factors are often regulated on 
the protein level by a rapid turnover, mediated by ubiquitin ligases (Moon et al., 
2004). Therefore, a yeast-two-hybrid screen in collaboration with J. Uhrig, University 
of Cologne, was used to search for putative interactors of HIG1/MYB51. 
Many eukaryotic transcription factors have a separated DNA binding domain (BD) 
and activation domain (AD) that can function independent of each other. The yeast-
two-hybrid assay takes advantage of this functional independence by separating BD 
and AD of the GAL4 transcription factor (Fig. 3.20). The BD is fused to a “bait” 
protein, the AD to “prey” proteins. Upon interaction of bait and prey, the BD and AD 
Figure 3.19: Dual choice assay with larvae of S. exigua. (A) scheme of the experimental 
setup with leaf a and b; (B) consumed leaf weight, when larvae were offered leaf a and b 
(mean ±SD; n=20). Asterisks denotes significant difference (Student’s t test; p<0.05).  
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come in close proximity and reconstitute a functional GAL4 transcription factor, which 
can drive GAL1-promoter controlled reporter gene expression. The system can either 
be used to analyse the interaction of specific bait and prey proteins, or it is used to 
screen for putative interacting proteins of a specific bait using a prey library. When 
working with transcription factors in a yeast-two-hybrid system one deals with the 
problem that the transcription factor used as bait protein can already contain an AD. 
Therefore, it can drive reporter gene expression without interacting with the prey 
fusion protein. As a consequence, proteins used as bait have to be tested for their 
ability to autoactivate the reporter gene prior to screening. It is known for R2R3 MYB 
factors that the AD usually resides in the carboxy terminal region. On the other hand, 
the R2R3 MYB domain, responsible for DNA binding and protein-protein interaction is  
located in the amino terminus. Consequently, a HIG1/MYB51 bait construct 
containing the amino terminal R2R3 MYB domain was constructed for the yeast-two-
hybrid screen (Fig. 3.21). In addition, three further constructs were used to narrow 
down the region of the actual activation domain. Construct B also contained the MYB 
domain and further extended to the amino acid stretch typical for subgroup 12 MYB 
factors. The third construct (C) was about 260 amino acids in length and contained 
two further cystein residues, possibly important for the mature protein conformation. 
Finally, construct D was generated to express the full-length HIG1/MYB51 protein. All 
four constructs were cloned into the Gateway compatible yeast expression vector 
pCD2-attR (Trp1+) for translational fusion with the GAL4 BD. Together with the empty 
prey plasmid pACT (Leu2+), the bait clones were then transformed into the AH109 
yeast strain, which contains the Gal1:His3 reporter construct. As a positive control for 
bait/prey interaction and activation of the Gal1:His3 reporter, the known interacting 
proteins SNF1 and SNF4 were used (Celenza and Carlson, 1989). The negative 
control consisted of an empty bait and empty prey vector. The cotransformed yeast 
cells were plated on -Trp/-Leu media to test for positive double transformands 
containing both plasmids, and on -Trp/-Leu/-His/+3AT to select for clones with 
Figure 3.20: Schematic representation of the yeast-two-hybrid assay. 
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Gal1:His3 reporter gene expression. Growth on -Trp/-Leu medium was observed for 
all contransformation assays (Tab. 3.3), indicating that none of the constructs is toxic 
for yeast and efficient transformation is possible. Furthermore, yeast cells 
transformed with both SNF1 and SNF4 as bait and prey were also growing on -Trp/-
Leu/-His/+3AT medium. The interaction of both proteins leads to reconstitution of the 
GAL4 BD and AD and a subsequent activation of the Gal1:His3 reporter, thus 
allowing growth on histidine-free medium. Additionally, transformation with the full-
length HIG1/MYB51 as bait (construct D) resulted in growth on -His medium. This 
clearly proved that the full length protein contains an activation domain in the carboxy 
terminus, which can drive reporter gene expression without the need for interaction 
with a prey fusion protein. Since none of the other constructs was autoactivating, the 
activation domain resides within the hundred amino acids of the carboxy terminal 
region of the HIG1/MYB51 protein. 
Figure 3.21: HIG1/MYB51 bait constructs generated for the yeast-two-hybrid assay. The R2 
MYB domain is indicated in blue, the R3 domain in green. The residues highlighted in red 
form the tryptophan cluster. The sequence highlighted in orange is the motif specific for
MYB factors of subgroup 12. 
Construct A 
 1 MVRTPCCKAE LGLKKGAWTP EEDQKLLSYL NRHGEGGWRT LPEKAGLKRC 
 51 GKSCRLRWAN YLRPDIKRGE FTEDEERSII SLHALHGNKW SAIARGLPGR 
101 TDNEIKNYWN THIKKRLIKK GI 
 
Construct B 
 1 MVRTPCCKAE LGLKKGAWTP EEDQKLLSYL NRHGEGGWRT LPEKAGLKRC 
 51 GKSCRLRWAN YLRPDIKRGE FTEDEERSII SLHALHGNKW SAIARGLPGR 
101 TDNEIKNYWN THIKKRLIKK GIDPVTHKGI TSGTDKSENL PEKQNVNLTT 
151 SDHDLDNDKA KKNNKNFGLS SASFLNKVAN RFGK 
 
Construct C 
 1 MVRTPCCKAE LGLKKGAWTP EEDQKLLSYL NRHGEGGWRT LPEKAGLKRC 
 51 GKSCRLRWAN YLRPDIKRGE FTEDEERSII SLHALHGNKW SAIARGLPGR 
101 TDNEIKNYWN THIKKRLIKK GIDPVTHKGI TSGTDKSENL PEKQNVNLTT 
151 SDHDLDNDKA KKNNKNFGLS SASFLNKVAN RFGKRINQSV LSEIIGSGGP 
201 LASTSHTTNT TTTSVSVDSE SVKSTSSSFA PTSNLLCHGT VATTPVSSNF 
251 DVDGNVNLTC S 
 
Construct D 
 1 MVRTPCCKAE LGLKKGAWTP EEDQKLLSYL NRHGEGGWRT LPEKAGLKRC 
 51 GKSCRLRWAN YLRPDIKRGE FTEDEERSII SLHALHGNKW SAIARGLPGR 
101 TDNEIKNYWN THIKKRLIKK GIDPVTHKGI TSGTDKSENL PEKQNVNLTT 
151 SDHDLDNDKA KKNNKNFGLS SASFLNKVAN RFGKRINQSV LSEIIGSGGP 
201 LASTSHTTNT TTTSVSVDSE SVKSTSSSFA PTSNLLCHGT VATTPVSSNF 
251 DVDGNVNLTC SSSTFSDSSV NNPLMYCDNF VGNNNVDDED TIGFSTFLND 
301 EDFMMLEESC VENTAFMKEL TRFLHEDEND VVDVTPVYER QDLFDEIDNY 
351 FG 
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Even though the focus of the yeast-two-hybrid screen was to search for interactors of 
the regulatory MYB domain, all three non-autoactivating constructs were used for a 
first mating with the prey libraries (Fig. 3.22). In total, 510 putative candidates were 
obtained after this mating, whereas most clones interacted with construct A (216; 
construct B: 166 clones, construct C: 128 clones). Initial sequencing of several 
candidates after colony PCR revealed a large number of false positives, mainly 
ribosomal proteins. To reduce the number of false positives, the PCR products were 
retransformed into the prey vector via gap repair in yeast and the resulting colonies 
were used for a second mating. This second mating was performed with construct A 
only, to screen for specific interactors of the MYB domain. After this selection step, 
the number of putative candidates was strongly reduced (99 in total; 61 originally 
interacting with clonstruct A; 38 with construct B, respectively) and these remaining 
candidates were sequenced. Interestingly, none of the clones originally interacting 
with construct C showed interaction with construct A in the second mating. This 
suggests that the carboxy terminal extension of construct C prevents binding of prey 
proteins to the MYB domain, an effect previously observed for other MYB factors 
(J. Uhrig, personal communication). Sequencing of the remaining clones revealed 
that some candidates were present several times whilst others were found only once, 
resulting in 47 individual candidates (Tab. 3.4). The sequence found most often, was 
that of At4g19700, which is assigned as E3 ubiquitin ligases and might play a role in 
protein turnover. Other proteins involved in protein degradation were also found, 
suggesting a regulation of HIG1/MYB51 on the posttranscriptional level. Apart from 
the candidates with a predicted function, most of the candidates had no assigned 
function (Table 3.4). Since it was not feasible within this study to analyse many 
candidates in detail, the most promising candidates were chosen for further 
investigation.  
Table 3.3: Testing of bait constructs for autoactivation 
bait prey growth on 
-Trp/-Leu 
growth on 
-Trp/-Leu/-His/+3AT 
empty vector empty vector + - 
SNF1 SNF4 + + 
construct A empty vector ++ - 
construct B empty vector ++ - 
construct C empty vector ++ - 
construct D empty vector + + 
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The interaction of MYB factors with bHLH proteins has been shown in several cases 
(Baudry et al., 2004). Therefore, the interacting ATR2/bHLH05 was considered a 
promising candidate, especially since the dominant allele of ATR2/bHLH05, atr2D, 
appeared to be implicated in the regulation of tryptophan biosynthesis (Smolen et al., 
2002). Furthermore, it could be shown that atr2D and the dominant overexpressor of 
ATR1/MYB34 (atr1D) have additive effects with respect to ASA1 activation or 5MT 
resistance. However, an interaction between both proteins could not be observed in a 
yeast-two-hybrid system, neither with the wild-type, nor the mutated form of 
ATR2/bHLH05 (Smolen et al., 2002). For that reason, it was all the more interesting 
that HIG1/MYB51, a close homologue of ATR1/MYB34, appeared to interact with 
ATR2/bHLH05.  
Figure 3.22: Work flow of the yeast-two-hybrid screen. The steps indicated in italics were 
performed by the AG Uhrig, University of Cologne and are described by Soellick and Uhrig
(2001). 
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3.13  HIG1/MYB51 and ATR2/bHLH05 interact in vivo 
The results obtained with the yeast-two-hybrid assay showed that HIG1/MYB51 and 
ATR2/bHLH05 are able to interact in yeast. However, many candidates pulled out by 
a yeast-two-hybrid screen are false positives, even after several rounds of selection. 
To test, whether both transcription factors also interact in a plant system, the 
bimolecular fluorescence assay was used (Walter et al., 2004). The system is based 
on the separation of the amino and carboxy terminal domain of YFP (“split-YFP”) and 
their fusion to putative interacting proteins. Upon binding of both fusion proteins, the 
two YFP domains come in close proximity to reconstitute a functional fluorescent 
protein. For that reason, the coding sequence of HIG1/MYB51 and ATR2/bHLH05 
were cloned into the respective binary vectors (Walter et al., 2004). HIG1/MYB51 
was fused to the amino terminus of YFP (pSPYN) and ATR2/bHLH05 was fused to 
the carboxy terminus (pSPYC). The plasmids were then transformed into 
hypervirulent agrobacteria, used for transient expression in tobacco via leaf 
infiltration. In a second assay, another nuclear localised bHLH factor, bHLH133, used 
in a different study was also cloned into pSPYC. An interaction with bHLH133 was 
not observed (Fig. 3.23B) and therefore suits as a nuclear localised negative control 
rather than an empty vector, which would target the protein to the cytoplasm. On the 
other hand, the interaction of HIG1/MYB51 and ATR2/bHLH05 could be clearly seen 
by the nuclear localised YFP signal in leaves infiltrated with the respective constructs 
(Fig. 3.23A). The plant based in vivo expression system thereby confirmed the results 
obtained by the yeast-two-hybrid assay.  
Figure 3.23: Split-YFP assay in agrobacteria infiltrated N. benthamiana leaves. (A) the YFP 
signal indicates the interaction of HIG1/MYB51 and ATR2/bHLH05; (B) bHLH133 did not 
interact with HIG1/MYB51. 
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3.14  ATR2/bHLH05 and HIG1/MYB51 expression overlap 
The interaction of HIG1/MYB51 and ATR2/bHLH05 could be shown both in the yeast 
system and by transient expression in tobacco. However, an interaction of both 
proteins in planta is only possible if both are expressed in the same organs or tissues 
at the same time. Therefore, the expression pattern of ATR2/bHLH05 was analysed 
using the GUS reporter and compared to the results obtained for HIG1/MYB51 
expression. The region upstream ATR2/bHLH05 (At5g46760) was amplified from 
genomic DNA (-1325 to -4) and cloned via Gateway into pGWB3 for promoter driven 
GUS expression. The construct was expressed in Arabidopsis through agrobacteria 
mediated stable transformation. More than 20 independent T1 plants were used for 
an initial screening and fifteen lines displaying the same qualitative expression 
pattern were analysed in more detail in the following generations. Promoter activity 
was detectable in the cotyledons of 7-day-old seedlings, mainly in the vasculature 
(Fig. 3.24A,B). Rosette leaves also showed strongest staining in the vasculature 
(Fig. 3.24C,D), but GUS activity was in general stronger in mature leaves than in 
young emerging leaves (Fig. 3.24C). Furthermore, GUS reporter expression was 
detectable in the main and lateral roots, with strongest staining in the cortical cells 
(Fig. 3.24E). The reproductive organs, namely flowers and siliques, displayed only 
faint promoter driven GUS activity. Blue staining could be seen in the vasculature of 
Figure 3.24: Histochemical GUS staining of ProATR2/bHLH05-GUS plants. (A) 7-day old 
seedling; (B) cotyledon; (C) 3-week old plant; (D) mature rosette leaf; (E) main and lateral
roots; (F) flower; (G) young silique. 
3 Results   
 
57
sepals and in the abscission zone of young siliques (Fig. 3.24F,G). Taken together, 
the promoter of ATR2/bHLH05 showed strongest activity in the vegetative organs. 
Faint and locally restricted GUS staining could be observed in flowers and siliques. A 
similar pattern was found for HIG1/MYB51 expression (section 3.4). Hence, 
ATR2/bHLH05 and HIG1/MYB51 appear to be coexpressed to a large extent under 
normal growth conditions. An interaction of the gene products, as seen by protein 
interaction assays, could therefore be possible in planta.  
3.15  ATR2/bHLH05 represses HIG1/MYB51 activation of indolic 
glucosinolate promoters 
It is known from other transcription factors that the interaction with other factors is an 
important part of target gene regulation. A well characterised example is 
TRANSPARENT TESTA2 (TT2)/MYB123 and TT8/bHLH42, which need to interact 
for the activation of the DIHYDROFLAVONOL REDUCTASE (DFR) promoter 
(Baudry et al., 2004). Therefore, it was interesting to investigate, whether the 
interaction of HIG1/MYB51 with ATR2/bHLH05 modulates its potential to induce 
indolic glucosinolate promoters (section 3.8). Furthermore, Smolen et al. (2002) 
showed in their study that a point mutation in ATR2/bHLH05 (atr2D), but not 
overexpression of the wild-type coding sequence led to the increased transcription of 
glucosinolate pathway genes. Plants with ectopic overexpression of wild-type 
ATR2/bHLH05 had neither an increased ASA1 transcript level nor increased 5MT 
tolerance. Hence, the effect of the mutant atr2D was also tested in one of the 
approaches. The point mutation was introduced via PCR into the wild-type CDS at 
the position described by Smolen et al. (2002; D94N exchange). Both, the mutated 
and the wild-type CDS were transformed into the overexpression vector pGWB2, to 
be used as effector constructs in cotransformation assays. The experimental setup 
reproduces the one described in section 3.8, however only the qualitative 
histochemical GUS staining of transfected cells is shown. The effect of 
ATR2/bHLH05 on the promoter activity of ASA1, CYP79B3 and CYP83B1 was tested 
as examples of the indolic glucosinolate pathway. Furthermore, the mutated effector 
atr2D was analysed with respect to its regulation of ASA1 and CYP83B1. The 
histochemical GUS staining of the transfected Arabidopsis cells indicates no 
background activity for cells transformed with the ProASA1-GUS construct, a moderate 
activity of the ProCYP79B3-GUS and ProCYP83B1-GUS construct (Fig. 3.25, column 1). 
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Cotransformation with the HIG1/MYB51 effector led to an activation of the two CYP 
promoters, indicated by the intense blue GUS staining (column 2). The promoter of 
ASA1 was indeed not activated, as seen in previous analyses (Fig. 3.14). 
Interestingly, when ATR2/bHLH05 was used as effector, there was no detectable 
GUS staining in any of the three setups (column 3). Even the background activity 
observed for the CYP79B3 and CYP83B1 promoter was not detectable. This 
suggests a repressive function of ATR2/bHLH05 on these promoters. The addition of 
HIG1/MYB51 as a second effector resulted in a low GUS expression driven by the 
CYP79B3 and CYP83B1 promoter (column 4), however below the level when 
HIG1/MYB51 was used alone. It seems that the repression by ATR2/bHLH05 can 
partially be rescued by HIG1/MYB51. However, it is not clear, whether this is 
mediated by interaction of the two proteins or if it is a dosage dependent regulation. 
Besides the wild-type ATR2/bHLH05 protein, the dominant mutant atr2D was tested. 
Even though overexpression of atr2D in planta results in an upregulation of ASA1 
(Smolen et al., 2002), this effect could not be seen in the cell based system (column 
5). There were no observable differences between the wild-type and the mutated 
effector, indicating a more complex in planta situation than mimicked in this cell-
based assay. Also the addition of HIG1/MYB51 had no different effect than observed 
for the wild-type ATR2/bHLH05 effector. It might be that the phenotype observed in 
Figure 3.25: Histochemical GUS staining of transfected Arabidopsis cells. Cells were
stained for 8 hours 4 days after transfection. The reporter constructs (in pGWB3i) are
indicated on the left, the effector constructs (in pGWB2) are indicated on top. The atr2D 
mutant contained the D94N point mutation compared to the ATR2 wild-type. 
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plants carrying the atr2D allele is the result of a more complex interaction with other 
factors than only with HIG1/MYB51. To overcome the limitation of this assay, the 
stable overexpression of ATR2/bHLH05 in HIG1-1D plants was attempted. However, 
none of the individual transformants (60 lines tested) showed upregulation of both 
transcripts at the same time.  
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4  Discussion 
4.1  HIG1/MYB51 is a positive regulator of indolic glucosinolate 
biosynthesis 
The properties of glucosinolates as defence compounds along with their role in the 
biotic stress response have been under investigation for a long time. Glucosinolate 
biosynthesis is regulated in a developmental manner (Petersen et al., 2002; Brown et 
al., 2003) but can also be influenced by environmental stimuli, such as pathogen 
attack or hormone treatment (Brader et al., 2001; Kliebenstein et al., 2002b; Mewis et 
al., 2005). Even though the elucidation of the biosynthesis pathway has advanced 
substantially due to the model plant Arabidopsis thaliana, little is known about the 
regulatory machinery controlling this process. So far, only few components that 
influence glucosinolate accumulation have been described. ATR1/MYB34 was shown 
to activate both IAA and indolic glucosinolate biosynthesis, playing a role in the 
homeostasis of both (Celenza et al., 2005). OBP2, a DNA-binding-with-one-finger 
(DOF) transcription factor, was also described as a component affecting 
glucosinolate biosynthesis (Skirycz et al., 2006). Furthermore, IQD1, a calmodulin-
binding nuclear protein, was shown to have a positive effect on glucosinolate 
accumulation and plant defence against herbivore attack (Levy et al., 2005).  
Here, HIG1/MYB51 is presented, as a new component that regulates glucosinolate 
biosynthesis. The activation-tagging line HIG1-1D was isolated from a screen for 
mutants with an altered secondary metabolite profile (Schneider et al., 2005). The 
line displayed a dominant high indolic glucosinolate chemotype, caused by an 
upregulation of the endogenous HIG1/MYB51 expression through the inserted 
enhancer element. HIG1/MYB51 encodes a nuclear localised R2R3-type MYB 
transcriptional regulator. The relation between HIG1/MYB51 expression and indolic 
glucosinolate accumulation could be demonstrated by analysing ectopic 
overexpression lines and a null mutant. High transcript levels of HIG1/MYB51 were 
correlated with an increased concentration of the major indolic glucosinolate I3M, but 
also the minor compounds 4MOI3M and 1MOI3M accumulated to higher amounts 
than in the wild-type (Fig. 3.9). Thereby, ectopic overexpression of HIG1/MYB51 
phenocopies the upregulation of the endogenous expression pattern in the HIG1-1D 
mutant. In contrast, a T-DNA knock-out line of HIG1/MYB51 (hig1-1) contained 
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significantly less glucosinolates than the wild-type, further confirming the gene-to-trait 
relation. HIG1/MYB51 therefore represents a new important regulator of indolic 
glucosinolate biosynthesis.  
Along with the high indolic glucosinolate level in the HIG1/MYB51 overexpression 
lines, a decreased content of the short-chain aliphatic glucosinolate 4MSOB was 
observed. A reason for that might be an interdependence of the two branches, 
possibly via feedback regulation (Hemm et al., 2003). An alternative explanation was 
proposed by Grubb and Abel (2006) as “limiting electron model”, where the 
cytochrome P450 monooxygenases (CYPs) of the different pathways compete for the 
NADPH pool as electron source. This would explain why upregulation of one 
glucosinolate branch results in downregulation of the other. However, it is also known 
that the glucosinolate composition, and not only the total amount, plays a crucial role 
(Giamoustaris and Mithen, 1995; Rask et al., 2000). Interestingly, the hig1-1 loss of 
function mutant accumulates less indolic and aliphatic glucosinolates at the same 
time, keeping the overall composition close to the wild-type pattern. It might be that 
under conditions of basal glucosinolates levels, there is a tendency to maintain a 
specific glucosinolate composition. Strong induction of glucosinolate biosynthesis by 
overexpression of HIG1/MYB51 or environmental stimuli could overrule this aspect 
and the “limiting electron model” would come into play, resulting in upregulation of 
only one glucosinolate branch and the alteration of the overall composition. 
Besides the effect of HIG1/MYB51 misexpression on the chemotype, an influence on 
the transcript profile could be shown. First of all, RT-PCR analyses of constitutive 
HIG1/MYB51 overexpressors indicated an upregulation of the biosynthesis pathway 
genes responsible for tryptrophan and indolic glucosinolate biosynthesis (Fig. 3.12). 
An upregulation of DHS1, TSB1 and CYP79B2/B3, CYP83B1, UGT74B1 and AtST5a 
could be observed, respectively. The upregulation of the tryptophan pathway is 
probably due to an increased demand of the precursor tryptophan. Indeed, a 
common regulation of the tryptophan and indolic glucosinolate pathway could be 
observed under stress conditions (Gachon et al., 2005) and HIG1/MYB51 might be a 
mediator of this regulation. At the same time, the genes coding for the key enzymes 
of the aliphatic glucosinolate biosynthesis (CYP79F1/F2, CYP83A1) were 
downregulated, in accordance with the low 4MSOB level, observed in these lines 
(Fig. 3.12; Fig. 3.9). Hence, the RT-PCR analysis of selected genes gave a first 
indication for an important role of HIG1/MYB51 in transcriptional regulation of at least 
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some glucosinolate pathway genes. The potential of HIG1/MYB51 to activate the 
promoters of several of these genes was tested in a cotransformation assay, taking 
advantage of the GUS reporter system. Activation by HIG1/MYB51 was observed for 
the promoters of DHS1, TSB1, CYP79B2/B3, CYP83B1 and AtST5a (Fig. 3.14). The 
promoter of ASA1 appeared to be unaffected by HIG1/MYB51. Consequently, 
HIG1/MYB51 has the potential to activate at least a subset of the indolic 
glucosinolate pathway genes in trans, supporting the idea of a positive transcriptional 
regulator.  
To further investigate the influence of HIG1/MYB51 on the total transcriptional profile 
in planta, ethanol inducible HIG1/MYB51 lines in the hig1-1 knock-out background 
were created and used for microarray analysis. However, only one set of experiments 
was conducted, rendering data difficult to interpret due to a lack of replicates. 
Nevertheless, analysis of the total transcript allowed the observation of certain 
tendencies. As seen in constitutive overexpression lines, an upregulation of indolic 
glucosinolate pathway genes was also observed 24 hours after HIG1/MYB51 
induction (Fig. 3.13). Genes upstream (ASB1, IGPS) and downstream (CYP83B1, 
UGT74B1, AtST5a) of tryptophan in the biosynthesis pathway were induced, 
confirming the RT-PCR analyses. 
Besides the observed effect on indolic glucosinolate pathway genes, the transcript 
levels of CYP71B15 and NITRILASE2 (NIT2) were upregulated 24 hours after 
HIG1/MYB51 induction. CYP71B15 is the rate limiting enzyme in camalexin 
biosynthesis, a branching pathway of indolic glucosinolate biosynthesis that also 
uses IAOx as precursor (Fig. 4.1; Glawischnig et al., 2004; Schuhegger et al., 2006). 
NIT2 is able to catalyze the synthesis of IAA from indole-3-acetonitrile (IAN), which in 
turn is a product of I3M decomposition by myrosinases. NIT2 transcription is only 
slightly elevated in constitutive HIG1/MYB51 overexpression lines (Gigolashvili et al., 
2007), unlike the strong activation observed after transient HIG1/MYB51 induction 
(Tab. 3.1). Despite the observed upregulation of NIT2, a high endogenous IAA level 
in the induced plants appeared unlikely. Many auxin-responsive genes were 
downregulated (Tab. 3.2), including IAA6 and IAA19 that are upregulated in high-
auxin mutants (Zhao et al., 2002), and a member of the GH3-like protein family 
(At4g03400; log10-ratio=-1.0). Modified GH3 promoter elements were used to 
generate the DR5 reporter, commonly used to monitor endogenous auxin levels 
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(Ulmasov et al., 1997). Therefore, the question remains, why the IAA synthesis gene 
NIT2 was upregulated, even though a low endogenous IAA level seemed likely.  
One explanation might be the competition of the different biosynthesis branches for 
the common precursors (Fig. 4.1). Even though the formation of a metabolon (i.e. 
multienzyme complex) has not been proven for glucosinolate biosynthesis, there are 
indications suggesting its existance (reviewed by Jorgensen et al., 2005; Nafisi et al., 
2006). If the activity of such a metabolon is increased, the precursor tryptophan or 
the intermediate IAOx might be less available for branching pathways. The 
upregulation of NIT2 and CYP71B15, involved in IAA and camalexin biosynthesis, 
respectively, might therefore be a response to the tryptophan and IAOx shortage, 
Figure 4.1: Simplified model of the IAA synthesis pathways in A. thaliana (modified after 
Zhao et al., 2002; Woodward and Bartel, 2005; Pollmann et al., 2006). Questionmarks 
indicate pathways with unknown enzymes. ASA1, anthranilate synthase alpha 1; ASB1,
anthranilate synthase beta 1; TSB1, tryptophan synthase beta 1; CYP, cytochrome P450
monooxygenase; UGT, S-glycolsytransferase; AtST, A. thaliana sulfotransferase; NIT, 
nitrilase; MYR, myrosinase; AAO1, indole-3-acetaldehyde oxidase, YUCCA, flavin 
monooxygenase-like protein; IAOx, indole-3-acetaldoxime; I3M, indole-3-ylmethyl 
glucosinolate; IAAId, indole-3-acetaldehyde; IAA, indole-3-acetic acid; IAN, indole-3-
acetonitrile. 
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rather than a direct induction by HIG1/MYB51. Interestingly, NIT2 is known to be 
induced upon pathogen attack and is thought to play only a minor role in de novo IAA 
biosynthesis under normal conditions (Pollmann et al., 2006). This further suggests 
that NIT2 might be activated under conditions of high I3M biosynthesis, when the 
normal IAA synthesis pathways are impaired due to a precursor shortage. Analyses 
of the transcription pattern of earlier time points after HIG1/MYB51 induction could 
reveal at which point NIT2 is induced. In addition, quantification of the camalexin 
content in response to HIG1/MYB51 upregulation could answer the question, 
whether HIG1/MYB51 is an activator of this pathway, or if the observed upregulation 
of CYP71B15 is a secondary response to a limitation of the precursor IAOx. 
4.2  HIG1/MYB51 is expressed at sites of indolic glucosinolate 
accumulation 
Since HIG1/MYB51 appeared to be a transcriptional regulator of glucosinolate 
biosynthesis, one would expect a coexpression with the putative target genes. The 
expression pattern of several pathway genes and the regulatory component IQD1 
and OBP2 have been described. Expression of IQD1 was observed in vegetative 
organs of non flowering plants (Levy et al., 2005). However, activity of the reporter 
construct diminished in the rosette during transition to the reproductive growth phase, 
when highest activity was observed in inflorescences and flower buds. Also OBP2 
expression was shown to co-localise with vascular tissue in above and below-ground 
organs (Skirycz et al., 2006) The promoter of CYP79B2 drove GUS reporter 
expression mainly in roots and cotyledons, but also in the vasculature of young and 
mature rosette leaves (Mikkelsen et al., 2000). Moreover, expression of UGT74B1 
was found mainly in vascular tissues, both in roots and leaves, a weak expression 
was observed in flowers (Grubb et al., 2004). Promoter activity of HIG1/MYB51 was 
also found in vascular tissues of roots and the rosette, but extended further to the 
surrounding mesophyll of mature rosette leaves (Fig. 3.7). Consequently, there is a 
partial overlap in the expression of HIG1/MYB51 and putative target genes.  
Besides the expression pattern of biosynthesis genes, the distribution and 
concentration of glucosinolates in various organs has been described for A. thaliana 
(ecotype Col-0) during ontogenesis (Petersen et al., 2002; Brown et al., 2003). 
Highest glucosinolate concentrations are found in siliques and seeds, mainly due to 
the accumulation of aliphatic glucosinolates. Even though indolic glucosinolates are 
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present in basically all organs, they appear most prominent in roots and mature 
rosettes. Hence, HIG1/MYB51 expression co-localises with sites of indolic 
glucosinolate biosynthesis and accumulation.  
4.3  HIG1/MYB51 plays a role in biotic stress response 
Production of secondary metabolites, such as glucosinolates, to increase plant 
resistance against environmental stress is a question of cost and benefit. Highest 
concentrations of defence compounds are usually found in the reproductive organs 
and seeds. On the other hand, vegetative organs contain fewer amounts of 
secondary metabolites, rendering them more vulnerable. To reduce the risk of severe 
damage, plants have evolved systems to perceive stress stimuli and react 
appropriately, by a transient activation of defence machineries. Apart from the basal 
level of glucosinolates present in unstressed plants, the biosynthesis can be 
drastically induced by wounding, hormone application, pathogen or herbivore attack 
(Brader et al., 2001; Kliebenstein et al., 2002a; Bednarek et al., 2005; Mewis et al., 
2005). The stress related induction of several pathway genes was demonstrated, and 
also IQD1, OBP2 and ATR1/MYB34 were shown to respond to wounding (Levy et al., 
2005; Skirycz et al., 2006). A basal expression of HIG1/MYB51 was found in 
vegetative organs, at sites of indolic glucosinolate accumulation. However, 
transcription of HIG1/MYB51 was rapidly induced by mechanical stimuli, such as 
wounding, touch or spraying (Fig. 3.15-3.17). In addition, the induction of 
HIG1/MYB51 by wounding or pathogen attack has been reported in previous 
microarray studies (Chen et al., 2002; Cheong et al., 2002; Thilmony et al., 2006). 
Despite a strong upregulation of HIG1/MYB51 shortly after stress application, the 
transcript level returned back to the basal level within hours. Therefore, HIG1/MYB51 
appears to be responsive to mechanical stimuli in a transient manner and it is 
tempting to speculate about a regulatory role of HIG1/MYB51 in mediating the 
increased indolic glucosinolate biosynthesis in response to biotic stress conditions. 
Additional evidence about an implication of HIG1/MYB51 in an early stress response 
comes from microarray experiments analysing the response to treatment with the 
protein synthesis inhibitor cycloheximide (Genevestigator database; 
www.genevestigator.ethz.ch). Samples treated with cycloheximide showed a 
drastically increased accumulation of HIG1/MYB51 transcripts in comparison to 
control conditions. This shows that the transcriptional machinery, necessary for 
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HIG1/MYB51 transcription, is independent of de novo protein biosynthesis and only 
requires the modification of existing transcription factors. Such a phenomenon has 
been reported for many genes involved in early steps of signalling pathways and 
those genes have been designated as “early responsive genes” (Herschman, 1991; 
Abel et al., 1995). Also HIG1/MYB51 might therefore be part of an early signal 
perception.  
To further investigate the potential of HIG1/MYB51 as part of the defence system, the 
resistance of the overexpression line HIG1-1D against a generalist herbivore was 
tested. In a dual choice assay, the high indolic glucosinolate leaves of HIG1-1D 
clearly appeared to be more resistant against the generalist herbivore S. exigua 
(Fig.3.19). Further evidence supporting the idea of HIG1/MYB51 as a regulator of 
herbivore resistance was provided by QTL mapping in a Col x Ler population 
(Kliebenstein et al., 2002a). A QTL conferring increased resistance to the generalist 
herbivore Trichoplusia ni was mapped to chromosome 1, in the region between 14-28 
cM. This region contains the At1g18570 locus, coding for HIG1/MYB51, indicating 
that HIG1/MYB51 might play a general role in the defence against generalist 
herbivores (Fig. 4.2). 
4.4  HIG1/MYB51 has a role distinct from its close homologue 
ATR1/MYB34 
Until recently, ATR1/MYB34 was regarded as a master regulator with respect to 
indolic glucosinolate biosynthesis and IAA homeostasis (Grubb and Abel, 2006). 
Here, HIG1/MYB51 is presented as an additional positive regulator of indolic 
glucosinolate biosynthesis, distinct of ATR1/MYB34. A dominant mutation of 
ATR1/MYB34 was first described with respect to an altered tryptophan regulation 
(Bender and Fink, 1998), identified in a screen for 5MT resistant mutants. The 
increased resistance to the tryptophan analogue results from a constitutive activation 
of ASA1 in the mutant line overexpressing ATR1/MYB34. On the other hand, 
HIG1/MYB51 overexpression lines are as sensitive to 5MT as wild-type Arabidopsis 
plants (Fig. 3.11). An activation of ASA1 was not observed in constitutive 
HIG1/MYB51 overexpressors or a transient activation assay in Arabidopsis cell 
cultures (Fig. 3.14). This shows that even though ATR1/MYB34 and HIG1/MYB51 
both activate tryptophan and indolic glucosinolate biosynthesis, there are differences 
regarding the influence on ASA1 transcription. A further variation between 
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ATR1/MYB34 and HIG1/MYB51 consists in the respective influence on the 
endogenous IAA level. On the one hand, strong ATR1/MYB34 overexpression lines 
have a significantly higher IAA level compared to wild-type plants (Fig. 3.10), 
accompanied by a severe high-auxin growth phenotype (Gigolashvili et al., 2007). On 
the other hand, constitutive upregulation of HIG1/MYB51 has only moderate 
influence on the IAA level (Fig. 3.10) and neither the dominant HIG1-1D nor the hig1-
1 knock-out line shows any informative growth phenotype. Furthermore, the transient 
induction of HIG1/MYB51 expression in the hig1-1 background is accompanied by 
the downregulation of numerous auxin-responsive genes. Whereas ATR1/MYB34 
appears to play a predominant role in the homeostasis of IAA and indolic 
glucosinolates, HIG1/MYB51 seems to specifically activate the latter only. This is 
further supported by the upregulation of genes acting downstream CYP83B1, i.e. 
UGT74B1 and AtST5a, by HIG1/MYB51 (Fig. 3.12-14), which was not observed for 
ATR1/MYB34 (Gigolashvili et al., 2007). 
An additional indication for the different roles of HIG1/MYB51 and ATR1/MYB34 is 
their distinct expression pattern. The expression of HIG1/MYB51 correlates with sites 
of indolic glucosinolate accumulation, rather than with sites of IAA synthesis. In 
contrast, the expression pattern of ATR1/MYB34 shows spatial and temporal 
differences compared to HIG1/MYB51 expression. Plants containing an 
ATR1/MYB34-GUS reporter construct display no GUS expression in mature rosette 
leaves. However, ATR1/MYB34 expression can be observed in the meristematic 
tissues of growing inflorescences and generative organs (Gigolashvili et al., 2007; 
microarray data analysed with www.genevestigator.ethz.ch). Therefore, 
ATR1/MYB34 expression appears to be absent from major sites of indolic 
glucosinolate accumulation. Furthermore, ATR1/MYB34 and HIG1/MYB51 respond 
differently to biotic stress conditions. ATR1/MYB34 is inducible by MeJA treatment 
and herbivore attack, but only hours after stress treatment (Smolen and Bender, 
2002; Skirycz et al., 2006). In contrast, HIG1/MYB51 is rapidly induced by wounding 
or other mechanical stimuli (Fig. 3.15-17) and seems to be involved in an early stress 
response. Even though ATR1/MYB34 and HIG1/MYB51 share common target genes, 
they differ with respect to their influence on IAA biosynthesis and ASA1 regulation, 
but also regarding their expression pattern and response to environmental stimuli.  
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4.5  Is HIG1/MYB51 differentially regulated in roots? 
Interestingly, biotic stress hormones such as MeJA, SA or the ethylene precursor 
ACC appeared to have little influence on HIG1/MYB51 expression in the aerial part of 
the plant (section 3.9-9.10), as reported for IQD1 (Levy et al., 2005). However, a 
differential regulation of HIG1/MYB51 seems to exist in the roots. Under control 
conditions, HIG1/MYB51 expression seems to be absent from the meristem but is 
present in the differentiation zone. Treatment with the ethylene precursor ACC results 
in a strong activation of the HIG1/MYB51 promoter in the root meristem (Fig. 3.18). 
Interestingly, the root tip is known to actively synthesise IAA, with highest synthesis 
rates in the meristem (Ljung et al., 2005). This is coherent with expression of ASA1, 
ASB1, CYP79B2 and CYP79B3 in the meristematic region (Stepanova et al., 2005; 
Ljung et al., 2005). Furthermore, the IAA synthesis in this tissue is inducible by 
ethylene treatment as monitored by the DR5 reporter and accompanied by a site 
specific upregulation of ASA1 and ASB1 (Stepanova et al., 2005). Therefore, the 
question arises, whether HIG1/MYB51 is involved in the ethylene-induced auxin 
biosynthesis in the root tips. A moderate activation of ASB1 was observed upon 
HIG1/MYB51 induction in rosette leaves, whereas ASA1 was unaffected (Fig. 3.13). 
Unfortunately, most studies about the regulation of IAA biosynthesis concentrated on 
the aerial parts of the plant and not on the root system. Furthermore, little is known 
about the differential regulation of ASA1 and ASB1, coding for the second subunit of 
anthranilate synthase. HIG1/MYB51 might be involved in the site specific regulation 
of IAA and/or indolic glucosinolate biosynthesis upon ethylene induction in the root 
meristem. However, further studies are needed to elucidate the differential regulation 
of auxin biosynthesis in aerial parts and the root system, also with respect to IAA and 
indolic glucosinolate homeostasis. 
4.6  Is HIG1/MYB51 part of a complex regulatory network? 
Analysis of the regulation of phenylpropanoid biosynthesis has revealed a complex 
regulation of the pathway genes, where multiple transcription factors come into play 
(Winkel-Shirley, 2002). A similar scenario might exist for the regulation of 
glucosinolate biosynthesis. A reason for that hypothesis is the close link of indolic 
glucosinolate and IAA biosynthesis (section 1.2). Furthermore, glucosinolates play a 
role in basal plant resistance but are also induced upon pathogen or herbivore attack. 
An increased IAA synthesis at the same time seems undesirable for the plant. 
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Consequently, a tight regulation of glucosinolate biosynthesis can be expected. First 
components of such a network have been presented (Smolen et al., 2002; Celenza 
et al., 2005; Levy et al., 2005; Skirycz et al., 2006). However, further evidence is 
suggesting a more complex situation. 
The yeast-two-hybrid screen presented in this study revealed a protein-protein 
interaction of HIG1/MYB51 with the bHLH transcription factor ATR2/bHLH05. This 
interaction could be confirmed in vivo using the “split-yfp” approach. In addition, 
cotransformation assays in Arabidopsis cell cultures suggest a repression of 
HIG1/MY51 action by ATR2/bHLH05. Therefore, HIG1/MYB51 and ATR2/bHLH05 
present the first described transcriptional regulators of indolic glucosinolate 
biosynthesis that interact with one another and thereby influence each other. 
However, this interaction needs to be further characterised in planta, with respect to 
the putative target genes and the glucosinolate profile. The generation of a double 
overexpression line was not successful, possibly due to the use of the CaMV 35S 
promoter or not enough lines tested. It could also be that HIG1/MYB51 and 
ATR2/bHLH05 not only interact but regulate each other. Different approaches will 
therefore be needed. First indications could come from the analysis of ATR2/bHLH05 
knock-out or knock-down plants, with respect to HIG1/MYB51 expression and 
activation of indolic glucosinolate pathway genes. A further possibility would be the 
transient overexpression of each gene in the reporter GUS lines of the respective 
other gene to elucidate a possible transcriptional regulation. 
Besides the observed interaction of HIG1/MYB51 and ATR2/bHLH05, several 
proteins involved in protein degradation were found within the yeast-two-hybrid 
screen. It is known from other transcriptional regulators that the specific protein 
turnover plays an important regulatory role (reviewed by Sullivan et al., 2003; Devoto 
and Turner, 2005). Indeed, the clone identified most often (17-times) was that of a 
putative E3-ubiquitin ligase (At4g19700), which is known to interact with other MYB 
transcription factors in yeast, namely MYB4, MYB6, MYB0 and MYB75 
(Zimmermann, 2003). Therefore, it is tempting to speculate, whether this E3-ubiquitin 
ligase plays a role in targeting specific MYB transcriptional regulators for degradation 
via the proteasome. However, an interaction of the E3 ligase with any of the MYB 
factors in planta still needs to be investigated. 
Not only in vitro screenings, but also in silico studies offer the possibility to find 
putative interacting genes. Looking at genes that are co-regulated with HIG1/MYB51 
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under pathogen-stress conditions, by means of the GeneAngler tool (Toufighi et al., 
2005), a link to the expression of MYB122, the closest homologue of MYB51/HIG1, 
can be observed. Ectopic overexpression of MYB122 in the wild-type background led 
to an increased transcript level of several genes involved in indolic glucosinolate 
biosynthesis and increased I3M levels (Gigolashvili et al., 2007). However, this 
induction was not observed when MYB122 was overexpressed in the hig1-1 
background. It seems that the positive regulatory role of MYB122 is dependent on 
functional HIG1/MYB51. MYB122 might act downstream HIG1/MYB51, or the two 
factors interact with each other. To further investigate this question, the yeast-two-
hybrid system was employed to assess a possible interaction of these two MYB 
factors. The amino terminal MYB domain of HIG1/MYB51 was used as bait 
(Fig. 3.21, construct A), the full length MYB122 as prey. The two constructs were 
tested by J. Uhrig, University of Cologne, and indeed a positive interaction of 
HIG1/MYB51 and MYB122 could be observed in the yeast system. So far, an 
interaction of two MYB factors was not reported for plant MYB transcription factors. 
Figure 4.3: Model of the regulatory network controlling indolic glucosinolate accumulation.
Known interactions are indicated. Question marks show where further studies are necessary 
to define an interaction or to place known regulators in the network. 
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This finding therefore presents a new and interesting possibility for the formation of 
transcriptional regulator complexes (Fig. 4.3). 
In addition to the observed interactions at the protein level, HIG1/MYB51 is certainly 
regulated on the transcriptional level (as discussed in sections 4.1 and 4.3). Ongoing 
studies gave first indications about a transcriptional control of MYB factors belonging 
to subgroup 12 by other members of the same subgroup. As a consequence, future 
work should focus on studying the interaction of the transcriptional regulators that 
control glucosinolate biosynthesis on the transcriptional and protein level (Fig. 4.3).  
 
 
Summarizing, HIG1/MYB51 is a positive regulator of indolic glucosinolate 
biosynthesis that activates pathway genes in trans and is expressed at sites of 
glucosinolate synthesis and accumulation. Furthermore, HIG1/MYB51 expression is 
rapidly inducible by biotic stress and a high HIG1/MYB51 transcript level, 
accompanied by an increased accumulation of indolic glucosinolates, confers 
increased resistance against generalist herbivores. Therefore, HIG1/MYB51 seems 
to be part of an early biotic stress response in A. thaliana. The interaction with the 
transcriptional regulators ATR2/bHLH05 and MYB122 suggest a complex regulatory 
network controlling indolic glucosinolate biosynthesis and future studies should aim at 
elucidating the specific role of the individual components of this network.  
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Table S4: Genes with significant up/downregulation by HIG1/MYB51 induction 
AGI code description log ratio
At1g18570 myb family transcription factor 1.61
At3g14900 hypothetical protein 1.37
At3g28510 hypothetical protein 1.21
At3g17790 acid phosphatase type 5 1.10
At3g44990 xyloglucan endotransglycosylase, putative 1.04
At3g11340 glucosyl transferase, putative 1.00
At5g49480 NaCl-inducible Ca2+-binding protein-like; calmodulin-like 0.92
At2g05380 expressed protein 0.91
At1g14880 unknown protein 0.91
At1g17170 glutathione transferase, putative 0.85
At4g25630 fibrillarin 2 (AtFib2) 0.80
At3g13310 DnaJ protein, putative 0.79
At1g33960 AIG1 0.77
At5g05250 expressed protein 0.77
At4g38620 putative transcription factor (MYB4) 0.76
At1g01520 myb family transcription factor 0.76
At3g26830 cytochrome p450 family 0.75
At5g09440 putative protein 0.74
At4g01870 hypothetical protein 0.72
At4g34131 similar to glucosyltransferase -like protein 0.71
At2g32960 unknown protein 0.70
At3g44300 nitrilase 2 0.68
At2g04450 putative mutT domain protein 0.67
At1g57630 disease resistance protein (TIR class), putative 0.67
At2g29460 glutathione transferase, putative 0.67
At2g29420 glutathione transferase, putative 0.67
At1g26790 Dof zinc finger protein 0.66
At1g07400 heat shock protein, putative 0.66
At4g21930 putative protein 0.66
At3g21150 CONSTANS B-box zinc finger family protein 0.65
At1g55850 cellulose synthase catalytic subunit, putative 0.64
At5g51440 mitochondrial heat shock 22 kd protein-like 0.63
At1g77450 GRAB1-like protein 0.62
At3g24500 ethylene-responsive transcriptional coactivator, putative 0.62
At1g56430 nicotianamine synthase, putative 0.62
At5g61020 putative protein 0.62
At1g13340 hypothetical protein 0.62
At3g09270 glutathione transferase, putative 0.62
At2g38860 expressed protein 0.61
At3g57150 putative protein 0.61
At5g55915 nucleolar protein-like 0.61
At5g11590 transcription factor TINY, putative 0.61
At3g22660 unknown protein 0.6
At3g21890 CONSTANS B-box zinc finger family protein 0.6
At3g56070 peptidylprolyl isomerase 0.59
At2g29490 glutathione transferase, putative 0.59
At4g38100 expressed protein 0.59
At2g44120 60S ribosomal protein L7 0.59
At3g04710 ankyrin-like protein 0.58
At1g02450 unknown protein 0.58
At3g59750 receptor lectin kinase-like protein 0.58
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Table S4: continued 
AGI code description log ratio
At4g13180 short-chain alcohol dehydrogenase like protein 0.58
At5g63790 putative protein 0.57
At4g15550 glucosyltransferase like protein 0.57
At5g03800 putative protein 0.57
At1g61800 glucose-6-phosphate/phosphate-translocator precursor, putative 0.57
At1g69530 expansin (At-EXP1) 0.57
At2g18660 hypothetical protein 0.56
At5g42760 putative protein 0.56
At1g48570 hypothetical protein 0.56
At4g31790 methyltransferase - like protein 0.56
At1g79160 hypothetical protein 0.55
At3g07050 putative GTPase 0.55
At5g40610 dihydroxyacetone 3-phosphate reductase (dhaprd) 0.55
At3g18950 hypothetical protein 0.55
At1g48630 guanine nucleotide-binding protein, putative 0.55
At1g01720 NAC domain protein, putative 0.55
At1g15100 putative RING-H2 zinc finger protein 0.54
At3g09440 heat-shock protein (At-hsc70-3) 0.54
At1g01680 hypothetical protein 0.54
At2g02930 glutathione transferase, putative 0.54
At1g05560 UDP-glucose transferase(UGT1) 0.54
At5g65860 putative protein 0.54
At3g30460 RING zinc finger protein 0.54
At1g52930 expressed protein 0.54
At5g22100 similar to Probable RNA 3-terminal phosphate cyclase-like protein. 0.53
At5g54130 putative protein 0.53
At5g52830 WRKY family transcription factor 0.53
At5g59850 cytoplasmic ribosomal protein S15a - like 0.52
At2g15020 hypothetical protein 0.52
At2g27840 unknown protein 0.52
At5g56030 HEAT SHOCK PROTEIN 81-2 (HSP81-2) (sp|P55737) 0.52
At3g47480 putative calcium-binding protein 0.52
At3g12580 heat shock protein 70 0.51
At5g08180 nhp2-like protein 0.51
At4g38210 expansin, putative 0.51
At4g35180 amino acid permease - like protein 0.51
At5g21940 unknown protein 0.51
At3g44750 putative histone deacetylase 0.51
At5g19300 putative protein 0.51
At2g16720 myb DNA-binding protein 0.5
At2g37190 60S ribosomal protein L12 0.5
At1g80750 ribosomal protein L7, putative 0.5
At5g60670 60S ribosomal protein L12 - like 0.5
At1g31660 bystin, putative 0.5
At3g13230 expressed protein 0.5
At1g25260 expressed protein 0.5
At3g57490 40S ribosomal protein S2 (RPS2D) 0.49
At4g12400 stress-induced protein sti1 -like protein 0.49
At5g56080 nicotianamine synthase, putative 0.49
At5g54120 unknown protein 0.49
At3g16780 putative ribosomal protein 0.49
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Table S4: continued 
AGI code description log ratio
At3g15990 putative sulfate transporter 0.48
At3g58660 putative protein 0.48
At4g39670 putative protein 0.48
At1g74310 heat shock protein 101 (HSP101) 0.48
At2g37270 40S ribosomal protein S5 0.48
At2g40700 DEAD/DEAH box RNA helicase protein, putative 0.48
At5g57280 protein carboxyl methylase-like 0.48
At5g22440 60S ribosomal protein L10A 0.48
At1g49600 RNA binding protein 47 (RBP47), putative 0.48
At4g24780 polysaccharide lyase family 1 (pectate lyase) 0.48
At2g20450 60S ribosomal protein L14 0.48
At3g61890 homeobox-leucine zipper protein ATHB-12 0.48
At2g33370 60S ribosomal protein L23 0.48
At5g61770 Peter Pan - like protein 0.48
At5g04950 nicotianamine synthase, putative 0.47
At4g23150 serine/threonine kinase - like protein 0.47
At4g30800 ribosomal protein S11 - like 0.47
At1g02920 glutathione transferase, putative 0.47
At1g18850 expressed protein 0.47
At3g28900 60S ribosomal protein L34, putative 0.47
At3g09350 expressed protein 0.47
At2g28600 putative ATP-dependent RNA helicase 0.47
At1g09180 putative GTP-binding protein, SAR1B 0.47
At1g65030 G-protein beta-subunit (transducin) family 0.47
At2g32220 60S ribosomal protein L27 0.47
At3g27060 ribonucleotide reductase small subunit, putative 0.47
At1g26770 expansin, putative 0.47
At1g48100 polygalacturonase, putative 0.47
At3g60360 putative protein 0.47
At2g20560 putative heat shock protein 0.46
At3g07860 unknown protein 0.46
At1g23280 mak16-like protein-related 0.46
At2g29350 putative tropinone reductase 0.46
At3g19030 expressed protein 0.46
At4g34138 similar to glucosyltransferase -like protein 0.46
At5g09530 surface protein PspC-related 0.46
At1g80130 expressed protein 0.46
At3g18130 protein kinase C-receptor/G-protein, putative 0.46
At1g12960 60S ribosomal protein L27a, putative 0.46
At4g31700 ribosomal protein S6 - like 0.46
At2g34260 G-protein beta-subunit (transducin) family 0.45
At1g75670 expressed protein 0.45
At3g23620 expressed protein 0.45
At2g32060 40S ribosomal protein S12 0.45
At5g04340 putative c2h2 zinc finger transcription factor 0.45
At3g02040 expressed protein 0.45
At3g07110 putative 60S ribosomal protein L13A 0.45
At1g04480 putative putative 60S ribosomal protein L17 0.45
At3g06530 hypothetical protein 0.45
At2g37770 aldo/keto reductase family 0.45
At3g53430 60S RIBOSOMAL PROTEIN L12 -like 0.44
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Table S4: continued 
AGI code description log ratio
At2g27395 putative cysteine proteinase 0.44
At3g54420 glycosyl hydrolase family 19 (class IV chitinase) 0.44
At2g31230 ethylene response factor, putative 0.44
At3g07750 putative 3 exoribonuclease 0.44
At1g29320 hypothetical protein 0.44
At1g63780 putative U3 small nucleolar ribonucleoprotein protein 0.44
At2g27420 cysteine proteinase 0.44
At5g20160 ribosomal protein L7Ae-like 0.44
At4g26780 grpE like protein 0.44
At5g39850 40S ribosomal protein S9-like 0.44
At5g27850 60S ribosomal protein - like 0.44
At1g72680 putative cinnamyl-alcohol dehydrogenase 0.44
At5g10930 serine/threonine protein kinase -like protein 0.43
At1g02460 polygalacturonase, putative 0.43
At4g27380 expressed protein 0.43
At4g10500 2-oxoglutarate-dependent dioxygenase family 0.43
At4g12600 Ribosomal protein L7Ae -like 0.43
At1g78080 AP2 domain protein RAP2.4 0.43
At5g52640 heat-shock protein 0.43
At3g49340 cysteine protease 0.43
At5g10360 40S ribsomal protein S6 0.43
At2g43570 glycosyl hydrolase family 19 (chitinase) 0.43
At3g16810 expressed protein 0.43
At2g45440 putative dihydrodipicolinate synthase 0.43
At3g17170 expressed protein 0.43
At1g26470 expressed protein 0.43
At5g61030 glycine-rich RNA-binding protein 0.43
At5g41040 N-hydroxycinnamoyl/benzoyltransferase-like protein 0.43
At1g61570 expressed protein 0.43
At1g70600 60S ribosomal protein L27A 0.43
At3g22970 unknown protein 0.42
At3g46080 zinc finger -like protein 0.42
At3g05590 putative 60S ribosomal protein L18 0.42
At5g02050 putative protein 0.42
At5g16130 40S ribosomal protein S7-like 0.42
At3g13940 unknown protein 0.42
At5g02450 60S ribosomal protein - like 0.42
At2g37600 60S ribosomal protein L36 0.42
At4g10450 putative ribosomal protein L9, cytosolic 0.42
At1g15250 putative 60s ribosomal protein L37 0.42
At3g01820 putative adenylate kinase 0.42
At2g36630 unknown protein 0.42
At5g25890 putative protein 0.41
At3g58700 ribosomal protein L11 -like 0.41
At5g38720 putative protein 0.41
At5g08620 DEAD/DEAH box RNA helicase, putative 0.41
At5g61170 40S ribsomal protein S19 - like 0.41
At3g62870 60S RIBOSOMAL PROTEIN L7A protein 0.41
At3g16050 putative ethylene-inducible protein 0.41
At5g56950 nucleosome assembly protein 0.41
At3g23830 glycine-rich RNA-binding protein 0.41
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Table S4: continued 
AGI code description log ratio
At4g11890 protein kinase - like protein 0.41
At5g22880 histone H2B like protein (emb|CAA69025.1) 0.41
At2g01290 putative ribose 5-phosphate isomerase 0.41
At5g48760 60S ribosomal protein L13a 0.41
At1g78380 glutathione transferase, putative 0.41
At1g03360 hypothetical protein 0.41
At2g46790 expressed protein 0.41
At1g26910 putative 60s ribosomal protein L10 0.41
At1g31630 MADS-box protein 0.41
At3g14990 4-methyl-5(b-hydroxyethyl)-thiazole monophosphate biosyn. protein, putative 0.41
At3g03450 RGA1-like protein 0.41
At5g22650 histone deacetylase-like protein 0.41
At2g27530 60S ribosomal protein L10A 0.41
At4g37370 cytochrome p450 family 0.4
At1g61870 expressed protein 0.4
At5g12110 elongation factor 1B alpha-subunit (emb|CAB64729.1) 0.4
At5g40770 prohibitin (gb|AAC49691.1) 0.4
At2g17630 putative phosphoserine aminotransferase 0.4
At3g51870 putative carrier protein 0.4
At5g15550 G-protein beta family 0.4
At3g05060 putative SAR DNA-binding protein-1 0.4
At4g16720 ribosomal protein 0.4
At2g39390 60S ribosomal protein L35 0.4
At3g10530 hypothetical protein 0.4
At2g36620 60S ribosomal protein L24 0.4
At5g09590 heat shock protein 70 (Hsc70-5) 0.4
At5g48330 regulator of chromosome condensation (cell cycle regulatory protein) like 0.4
At3g47370 40S ribosomal protein S20-like protein 0.4
At1g33120 ribosomal protein L9, putative 0.4
At3g53460 29 kDa ribonucleoprotein, chloroplast precursor (RNA-binding protein cp29) 0.4
At5g65360 histone H3 (sp|P05203) 0.4
At2g47990 unknown protein 0.4
At1g08250 expressed protein 0.4
At2g40360 putative WD-40 repeat protein 0.4
At1g55920 serine acetyltransferase 0.4
At3g49910 60S RIBOSOMAL PROTEIN - like 0.4
At5g23310 iron superoxide dismutase (FSD3) 0.4
At1g15440 hypothetical protein 0.39
At4g02520 glutathione transferase, putative 0.39
At5g08400 putative protein 0.39
At5g20630 germin-like protein 0.39
At2g31160 expressed protein 0.39
At4g03450 hypothetical protein 0.39
At3g60245 Expressed protein 0.39
At5g54840 SGP1 monomeric G-protein (emb|CAB54517.1) 0.39
At1g26880 60s ribosomal protein L34 0.39
At3g47420 putative protein 0.39
At5g66540 expressed protein 0.39
At1g22780 putative 40S ribosomal protein S18 0.39
At4g15000 ribosomal protein 0.39
At5g51570 putative protein 0.39
Appendix    
 
91
Table S4: continued 
AGI code description log ratio
At5g25460 putative protein 0.38
At2g33210 mitochondrial chaperonin (HSP60) 0.38
At2g21560 unknown protein 0.38
At4g05410 U3 snoRNP-associated-related 0.38
At2g19730 putative ribosomal protein L28 0.38
At1g61580 ribosomal protein 0.38
At1g58983 40S ribosomal protein S2, putative 0.38
At4g39780 AP2 domain transcription factor RAP2, putative 0.38
At2g26150 putative heat shock transcription factor 0.38
At1g14320 tumor suppressor, putative 0.38
At5g01340 mitochondrial carrier protein family 0.38
At5g58770 dehydrodolichyl diphosphate synthase (DEDOL-PP synthase), putative 0.38
At1g57660 60S ribosomal protein L21, putative 0.38
At5g20290 putative protein 0.38
At4g10480 putative alpha NAC 0.38
At5g19750 putative protein 0.38
At3g49010 60S ribosomal protein L13, BBC1 protein 0.38
At1g08360 60S ribosomal protein L10A, putative 0.38
At2g41840 40S ribosomal protein S2 (RPS2C) 0.38
At5g15750 ribosomal protein-like 0.38
At5g04800 40S ribosomal protein S17 -like 0.38
At2g01250 putative ribosomal protein L7 0.38
At1g07070 ribosomal protein, putative 0.38
At1g43910 unknown protein 0.38
At4g16630 DEAD/DEAH box RNA helicase, putative 0.38
At1g57860 60S ribosomal protein L21, putative 0.38
At1g58684 similar to ribosomal protein S2, putative 0.37
At2g34480 60S ribosomal protein L18A 0.37
At4g17390 60S ribosomal protein L15 homolog 0.37
At5g56010 heat shock protein 90 0.37
At4g27490 putative protein 0.37
At1g14050 Expressed protein 0.37
At3g04770 40S ribosomal protein SA (RPSaB) 0.37
At5g64000 3(2),5-bisphosphate nucleotidase (emb|CAB05889.1) 0.37
At3g25520 ribosomal protein, putative 0.37
At5g37960 putative protein 0.37
At3g04840 putative 40S ribosomal protein S3A (S phase specific) 0.37
At1g51060 histone H2A, putative 0.37
At1g23100 10kDa chaperonin (CPN10), putative 0.37
At5g14520 pescadillo - like protein 0.37
At5g17760 BCS1 - like protein 0.37
At2g19310 putative small heat shock protein 0.37
At5g09510 ribosomal protein S15-like 0.37
At1g48920 nucleolin, putative 0.37
At3g22910 potential calcium-transporting ATPase 13 0.37
At1g74560 putative SET protein, phospatase 2A inhibitor 0.37
At2g44860 60S ribosomal protein L30 0.36
At5g52810 putative protein 0.36
At5g03230 putative protein 0.36
At1g33390 RNA helicase, putative 0.36
At4g25730 putative protein 0.36
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AGI code description log ratio
At3g57000 putative protein 0.36
At5g27990 putative protein 0.36
At2g18690 expressed protein 0.36
At3g03920 putative GAR1 protein 0.36
At3g22230 ribosomal protein L27, putative 0.36
At2g42740 60S ribosomal protein L11B 0.36
At5g56710 60S ribosomal protein L31 0.36
At1g54690 histone H2A, putative 0.36
At3g60770 ribosomal protein S13 -like 0.36
At5g52470 fibrillarin 1 AtFib1/SKIP7 0.36
At2g46210 delta-8 sphingolipid desaturase, putative 0.36
At1g27470 hypothetical protein 0.36
At4g36130 putative ribosomal protein L8 0.36
At1g60640 hypothetical protein 0.36
At1g45160 hypothetical protein 0.36
At4g02380 late embryogenesis abundant protein-related 0.36
At1g15425 expressed protein 0.36
At1g34030 ribosomal protein S18, putative 0.36
At5g50200 putative protein 0.36
At4g37090 expressed protein 0.36
At4g31500 cytochrome p450 family 0.35
At3g24520 heat shock transcription factor HSF1, putative 0.35
At3g09200 putative 60S acidic ribosomal protein P0 0.35
At4g37610 putative protein 0.35
At1g66580 60S ribosomal protein L10, putative 0.35
At5g40130 60S RIBOSOMAL PROTEIN L5 -like 0.35
At4g22530 putative protein 0.35
At3g13150 hypothetical protein 0.35
At3g23990 mitochondrial chaperonin hsp60 0.35
At1g08570 putative thioredoxin 0.35
At5g13170 senescence-associated protein (SAG29) 0.35
At4g32290 putative protein 0.35
At1g67430 ribosomal protein, putative 0.35
At5g67510 60S ribosomal protein L26 0.35
At5g08610 DEAD/DEAH box RNA helicase, putative 0.35
At2g21790 putative ribonucleoside-diphosphate reductase large subunit 0.35
At2g19640 putative SET-domain transcriptional regulator 0.35
At1g69200 fructokinase (Frk1), putative 0.35
At3g55010 phosphoribosylformylglycinamidine cyclo-ligase precursor 0.34
At3g23000 SNF1 related protein kinase (ATSRPK1) 0.34
At5g59870 histone H2A - like protein 0.34
At1g74100 putative flavonol sulfotransferase 0.34
At4g32720 RRM-containing protein 0.34
At5g60790 ABC transporter family protein 0.34
At2g37640 expansin, putative 0.34
At1g74890 response regulator 7, putative 0.34
At1g22400 UDP-glucose glucosyltransferase, putative 0.34
At5g03690 fructose-bisphosphate aldolase -like protein 0.34
At5g54470 CONSTANS B-box zinc finger family protein 0.34
At5g15950 S-adenosylmethionine decarboxylase (adoMetDC2) 0.34
At3g16080 putative ribosomal protein 0.34
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AGI code description log ratio
At3g25890 AP2 domain transcription factor, putative 0.34
At3g48930 cytosolic ribosomal protein S11 0.34
At5g14050 putative protein 0.34
At1g78190 unknown protein 0.34
At5g16970 quinone oxidoreductase -like protein 0.34
At5g22320 expressed protein 0.34
At3g60440 putative protein 0.34
At1g07930 elongation factor 1-alpha (EF-1-alpha) 0.34
At5g02870 60S ribosomal protein - like 0.34
At2g20690 putative riboflavin synthase alpha chain 0.34
At5g17600 RING-H2 zinc finger protein-like 0.34
At3g20000 membrane import protein, putative 0.33
At1g80270 hypothetical protein 0.33
At1g27050 homeobox RRM-containing protein 0.33
At3g17465 ribosomal protein L3 0.33
At3g16770 AP2 domain protein RAP2.3 0.33
At3g13790 glycosyl hydrolase family 32 0.33
At3g52380 chloroplast RNA-binding protein cp33 0.33
At5g12910 histone H3 -like protein 0.33
At1g18800 expressed protein 0.33
At2g21580 40S ribosomal protein S25 0.33
At2g25000 WRKY family transcription factor 0.33
At5g62440 putative protein 0.33
At5g52380 putative protein 0.33
At3g27180 hypothetical protein 0.33
At1g08580 hypothetical protein 0.33
At2g19670 putative arginine N-methyltransferase 0.33
At2g29760 hypothetical protein 0.33
At4g02230 putative ribosomal protein L19 0.32
At4g13850 glycine-rich RNA-binding protein AtGRP2 0.32
At3g09630 putative 60S ribosomal protein L1 0.32
At3g17610 bZIP family transcription factor 0.32
At1g32900 starch synthase, putative 0.32
At1g24100 UDP-glycosyltransferase family 0.32
At5g61820 putative protein 0.32
At5g27770 60S ribosomal protein L22 - like 0.32
At5g55580 putative protein 0.32
At1g15930 40S ribosomal protein S12, putative 0.32
At2g36530 enolase (2-phospho-D-glycerate hydroylase) 0.32
At1g10490 unknown protein 0.32
At4g37990 cinnamyl-alcohol dehydrogenase ELI3-2 0.32
At3g52060 putative protein 0.32
At3g10610 putative 40S ribosomal protein S17 0.32
At4g26230 putative ribosomal protein 0.32
At4g34740 amidophosphoribosyltransferase 2 precursor 0.32
At2g04400 putative indole-3-glycerol phosphate synthase 0.32
At4g34200 Phosphoglycerate dehydrogenase - like protein 0.32
At5g28540 luminal binding protein 0.32
At1g07350 transformer serine/arginine-rich ribonucleoprotein, putative 0.32
At5g14040 mitochondrial phosphate translocator 0.32
At4g02930 mitochondrial elongation factor Tu 0.32
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At2g23380 curly leaf protein (polycomb-group) 0.32
At5g02960 putative protein 0.32
At1g62380 1-aminocyclopropane-1-carboxylate oxidase (ACC oxidase), putative 0.32
At1g25083 F5A9.7 0.31
At5g02500 dnaK-type molecular chaperone hsc70.1 0.31
At4g24230 putative protein 0.31
At1g08410 unknown protein 0.31
At5g24840 methyltransferase-like protein 0.31
At2g04430 putative mutT domain protein 0.31
At1g09080 putative luminal binding protein 0.31
At3g27280 prohibitin, putative 0.31
At2g45030 mitochondrial elongation factor, putative 0.31
At3g02080 putative 40S ribosomal protein S19 0.31
At1g60730 auxin-induced protein, putative 0.31
At1g04360 hypothetical protein 0.31
At4g23570 phosphatase like protein 0.3
At3g51800 putative nuclear DNA-binding protein G2p 0.3
At1g79410 hypothetical protein 0.3
At5g19600 putative protein 0.3
At5g65010 asparagine synthetase (gb|AAC72837.1) 0.3
At2g47060 putative protein kinase -0.3
At4g20260 endomembrane-associated protein -0.31
At5g01710 putative protein -0.31
At5g57660 CONSTANS-like B-box zinc finger protein-like -0.31
At2g01450 putative MAP kinase -0.31
At1g63800 E2, ubiquitin-conjugating enzyme 5 (UBC5) -0.31
At1g12710 hypothetical protein -0.31
At4g37470 putative protein -0.31
At2g23130 arabinogalactan-protein (AGP17) -0.31
At3g19970 expressed protein -0.31
At3g45730 putative protein -0.31
At5g27520 mitochondrial carrier protein family -0.31
At2g45170 putative microtubule-associated protein -0.32
At5g25610 dehydration-induced protein RD22 -0.32
At3g28300 At14a -0.32
At4g21570 putative protein -0.32
At1g06540 hypothetical protein -0.32
At5g42200 putative protein -0.32
At4g03210 xyloglucan endotransglycosylase, putative -0.32
At3g53800 putative protein -0.32
At1g52290 protein kinase, putative -0.32
At5g45280 pectinacetylesterase, putative -0.32
At2g32090 expressed protein -0.33
At1g35612 hypothetical protein -0.33
At3g57450 putative protein -0.33
At1g13210 potential phospholipid-transporting ATPase 11 -0.33
At1g21500 expressed protein -0.33
At5g04040 expressed protein -0.33
At2g44840 putative ethylene response element binding protein (EREBP) -0.33
At3g28290 At14a -0.33
At1g26920 expressed protein -0.33
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At4g23590 tyrosine transaminase like protein -0.33
At3g57530 calcium-dependent protein kinase -0.33
At4g30660 stress responsive protein homolog -0.33
At3g50650 scarecrow-like 7 (SCL7) -0.33
At5g10750 putative protein -0.34
At5g40340 PWWP domain protein -0.34
At4g24380 putative protein -0.34
At1g53580 glyoxalase II, putative (hydroxyacylglutathione hydrolase) -0.34
At4g29310 putative protein -0.34
At3g05490 expressed protein -0.34
At5g11740 arabinogalactan-protein (AGP15) -0.34
At2g46140 putative desiccation related protein -0.34
At1g33970 expressed protein -0.34
At1g54100 aldehyde dehydrogenase homolog, putative -0.34
At3g53990 expressed protein -0.34
At4g13830 DnaJ-like protein -0.34
At4g08930 putative protein disulfide isomerase -0.35
At5g57800 lipid transfer protein; glossy1 homolog -0.35
At1g61670 hypothetical protein -0.35
At4g29780 expressed protein -0.35
At1g76600 expressed protein -0.35
At5g24420 6-phosphogluconolactonase-like protein -0.35
At2g32800 putative protein kinase -0.36
At5g23280 unknown protein -0.36
At4g12730 fasciclin-like arabinogalactan-protein (FLA2) -0.36
At5g24590 NAC2-like protein -0.36
At2g39800 delta-1-pyrroline 5-carboxylase synthetase (P5C1) -0.36
At3g23750 receptor-like kinase, putative -0.36
At5g08330 putative protein -0.36
At1g55330 arabinogalactan-protein (AGP21) -0.36
At1g11380 expressed protein -0.36
At2g39180 putative protein kinase -0.36
At4g02350 hypothetical protein -0.36
At2g45660 MADS-box protein (AGL20) -0.37
At3g45640 mitogen-activated protein kinase 3 -0.37
At5g50900 putative protein -0.37
At4g24360 putative protein -0.37
At1g21120 O-methyltransferase 1, putative -0.37
At4g08870 putative arginase -0.37
At4g30280 xyloglucan endotransglycosylase, putative -0.37
At3g10720 putative pectinesterase -0.37
At2g20340 putative tyrosine decarboxylase -0.37
At5g54490 putative protein -0.37
At3g28200 peroxidase, putative -0.37
At1g10080 hypothetical protein -0.37
At4g05150 putative protein -0.37
At5g23130 unknown protein -0.37
At3g50800 putative protein -0.37
At3g54020 putative protein -0.37
At4g36010 thaumatin-like protein -0.38
At2g32150 putative hydrolase -0.38
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At1g13260 DNA-binding protein (RAV1) -0.38
At1g03870 fasciclin-like arabinogalactan-protein (FLA9) -0.38
At1g29440 auxin-induced protein, putative -0.38
At1g76360 putative protein kinase -0.38
At1g57680 hypothetical protein -0.38
At2g42540 cold-regulated protein cor15a precursor -0.38
At2g18300 expressed protein -0.39
At2g01850 xyloglucan endotransglycosylase (EXGT-A3) -0.39
At1g72240 hypothetical protein -0.39
At2g30360 putative protein kinase -0.39
At4g17615 calcineurin B-like protein 1 -0.39
At5g61810 peroxisomal Ca-dependent solute carrier - like protein -0.39
At1g76160 pectinesterase (pectin methylesterase), putative -0.39
At3g50950 disease resistance protein (CC-NBS-LRR class), putative -0.39
At3g07470 expressed protein -0.39
At1g01140 serine threonine kinase, putative -0.39
At5g43760 beta-ketoacyl-CoA synthase, putative -0.39
At2g15960 expressed protein -0.39
At5g37710 calmodulin-binding heat-shock protein -0.39
At1g20440 hypothetical protein -0.39
At4g18280 glycine-rich cell wall protein-like -0.4
At4g14690 Expressed protein -0.4
At1g73080 leucine-rich repeat transmembrane protein kinase, putative -0.4
At5g48850 putative protein -0.4
At1g14330 hypothetical protein -0.4
At2g23120 expressed protein -0.4
At1g01240 expressed protein -0.4
At1g02900 hypothetical protein -0.4
At1g15550 gibberellin 3 beta-hydroxylase (GA4) -0.4
At4g33920 putative protein -0.4
At5g62520 putative protein -0.4
At1g07000 leucine zipper protein, putative -0.4
At4g23600 tyrosine transaminase like protein -0.4
At5g43440 1-aminocyclopropane-1-carboxylate oxidase -0.4
At2g28305 expressed protein -0.4
At4g23180 serine/threonine kinase -like protein -0.4
At1g56660 hypothetical protein -0.4
At4g15800 Expressed protein -0.4
At1g06360 fatty acid desaturase family protein -0.4
At1g69830 putative alpha-amylase -0.4
At2g36410 expressed protein -0.4
At3g07460 Expressed protein -0.4
At3g59310 putative protein -0.4
At1g52000 myrosinase binding protein, putative -0.41
At4g25620 unknown protein -0.41
At1g61260 cotton fiber expressed protein, putative -0.41
At4g26690 putative protein -0.41
At2g30500 unknown protein -0.41
At5g19530 spermine synthase (ACL5) -0.41
At4g27440 protochlorophyllide reductase precursor -0.41
At1g68580 unknown protein -0.41
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At1g36370 putative hydroxymethyltransferase -0.41
At4g35110 putative protein -0.41
At4g34760 putative auxin-regulated protein -0.41
At2g43290 putative calcium binding protein -0.41
At1g14280 phytochrome kinase substrate 1, putative -0.41
At1g09070 expressed protein -0.42
At1g21130 O-methyltransferase 1, putative -0.42
At1g60140 trehalose-6-phosphate synthase, putative -0.42
At4g24530 PsRT17-1 like protein -0.42
At1g07720 beta-ketoacyl-CoA synthase family -0.42
At5g52310 low-temperature-induced protein 78 (sp|Q06738) -0.42
At3g02570 putative mannose-6-phosphate isomerase -0.42
At3g45260 zinc finger protein -0.42
At2g16660 nodulin-like protein -0.42
At1g22160 expressed protein -0.42
At2g29630 putative thiamin biosynthesis protein -0.42
At5g44130 fasciclin-like arabinogalactan-protein, putative (FLA13) -0.42
At5g04020 Calmodulin-binding protein -0.42
At4g36730 G-box-binding factor 1 -0.42
At5g12940 leucine rich repeat protein family -0.42
At1g17990 12-oxophytodienoate reductase, putative -0.42
At3g47570 leucine-rich repeat transmembrane protein kinase, putative -0.42
At2g42760 unknown protein -0.42
At1g01470 hypothetical protein -0.42
At4g19530 disease resistance protein (TIR-NBS-LRR class), putative -0.42
At1g69370 chorismate mutase, putative -0.42
At2g41100 calmodulin-like protein -0.43
At3g22740 putative selenocysteine methyltransferase -0.43
At5g13400 peptide transporter - like protein -0.43
At5g44360 FAD-linked oxidoreductase family -0.43
At3g23030 auxin-inducible gene (IAA2) -0.43
At1g24170 putative glycosyl transferase -0.43
At2g28120 nodulin-like protein -0.43
At3g59440 calmodulin-like protein -0.43
At2g44230 expressed protein -0.43
At4g02540 CHP-rich zinc finger protein, putative -0.43
At2g38760 putative annexin -0.43
At1g58200 unknown protein -0.43
At1g23390 Kelch repeat containing F-box protein family -0.43
At4g16950 disease resistance protein, RPP5-like (TIR-NBS-LRR class), putative -0.43
At4g13340 extensin-like protein -0.43
At3g16470 putative lectin -0.43
At3g61260 putative DNA-binding protein -0.43
At4g30440 nucleotide sugar epimerase-like protein -0.43
At1g51940 unknown protein -0.44
At1g05805 bHLH protein -0.44
At3g29320 glucan phosphorylase, putative -0.44
At1g51805 receptor protein kinase, putative -0.44
At3g04910 putative mitogen activated protein kinase kinase -0.44
At1g33240 DNA-binding factor, putative -0.44
At1g79700 ovule development protein, putative -0.44
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At2g30250 WRKY family transcription factor -0.44
At5g40380 receptor-like protein kinase -0.44
At2g25250 unknown protein -0.44
At2g14080 disease resistance protein (TIR-NBS-LRR class), putative -0.44
At5g03120 putative protein -0.44
At2g38310 expressed protein -0.44
At1g69890 expressed protein -0.44
At4g20860 FAD-linked oxidoreductase family -0.44
At4g16860 disease resistance protein (TIR-NBS-LRR class), putative -0.44
At1g14240 putative nucleoside triphosphatase -0.44
At3g60290 2-oxoglutarate-dependent dioxygenase family -0.45
At5g25440 putative protein kinase -0.45
At5g11070 putative protein -0.45
At1g27770 calcium-transporting ATPase 1 -0.45
At1g72520 putative lipoxygenase -0.45
At1g22740 Ras-related GTP-binding protein (Rab7) -0.45
At1g57590 pectinacetylesterase, putative -0.45
At2g42530 cold-regulated protein cor15b precursor -0.45
At1g18400 helix-loop-helix protein homolog, putative -0.45
At5g15500 putative protein -0.45
At1g75380 wound-responsive protein, putative -0.46
At2g19620 putative SF21 protein {Helianthus annuus} -0.46
At1g02660 expressed protein -0.46
At1g73830 putative helix-loop-helix DNA-binding protein -0.46
At3g62660 putative protein -0.46
At3g04290 putative GDSL-motif lipase/acylhydrolase -0.46
At1g24530 G-protein beta family -0.46
At3g51970 wax synthase-like protein -0.46
At1g02390 expressed protein -0.46
At5g47220 ethylene responsive element binding factor 2 (EREBP-2) -0.46
At2g06050 12-oxophytodienoate reductase (OPR3)(DDE1) -0.46
At4g35470 putative protein -0.47
At3g24550 protein kinase, putative -0.47
At5g42250 alcohol dehydrogenase -0.47
At5g41750 disease resistance protein (TIR-NBS-LRR class), putative -0.47
At2g43010 expressed protein -0.47
At3g51550 receptor-protein kinase-like protein -0.47
At2g29290 putative tropinone reductase -0.47
At4g32350 putative protein -0.47
At4g38690 putative protein -0.47
At4g34260 hypothetical protein -0.47
At1g19570 dehydroascorbate reductase, putative -0.47
At1g28230 purine permease -0.47
At5g23660 MtN3-like protein -0.47
At4g11280 ACC synthase (AtACS-6) -0.47
At3g55940 phosphoinositide specific phospholipase C, putative -0.47
At4g35480 RING-H2 finger protein RHA3b -0.47
At1g66150 receptor protein kinase (TMK1), putative -0.48
At1g75220 integral membrane protein, putative -0.48
At4g15210 glycosyl hydrolase family 14 (beta-amylase) -0.48
At5g65470 putative protein -0.48
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At5g14120 nodulin-like protein -0.48
At1g69760 expressed protein -0.48
At3g13750 glycosyl hydrolase family 35 (beta-galactosidase) -0.48
At4g03390 leucine-rich repeat transmembrane protein kinase, putative -0.48
At2g43530 putative trypsin inhibitor -0.48
At1g20160 subtilisin-like serine protease -0.48
At5g51190 putative protein -0.48
At4g01330 putative protein kinase -0.48
At4g01950 unknown protein -0.48
At2g31800 putative protein kinase -0.48
At1g73750 expressed protein -0.48
At1g74430 myb family transcription factor -0.49
At4g18970 Expressed protein -0.49
At3g44860 methyltransferase-related -0.49
At1g44350 gr1 protein -0.49
At1g74950 expressed protein -0.49
At5g07580 transcription factor-like protein -0.49
At5g58900 I-box binding factor - like protein -0.49
At5g18130 putative protein -0.49
At5g05440 putative protein -0.49
At3g04640 expressed protein -0.49
At5g01740 putative protein -0.49
At3g62420 bZIP family transcription factor -0.49
At5g15350 putative protein -0.49
At1g27460 calmodulin-binding protein -0.5
At4g32790 putative protein -0.5
At3g04210 disease resistance protein (TIR-NBS class), putative -0.5
At1g52410 myosin-like protein -0.5
At2g30610 unknown protein -0.5
At1g29670 lipase/hydrolase, putative -0.5
At4g34250 fatty acid elongase 1 (FAE1), putative -0.5
At5g66210 calcium-dependent protein kinase -0.5
At5g62090 putative protein -0.51
At3g02070 unknown protein -0.51
At5g37770 CALMODULIN-RELATED PROTEIN 2, TOUCH-INDUCED (TCH2) -0.51
At5g44680 putative protein -0.51
At2g33570 expressed protein -0.51
At2g27500 glycosyl hydrolase family 17 -0.51
At2g30990 hypothetical protein -0.51
At4g04840 putative protein -0.51
At4g32800 transcription factor TINY, putative -0.51
At2g41430 ERD15 protein -0.51
At4g22780 Translation factor EF-1 alpha - like protein -0.52
At1g24070 glucosyltransferase, putative -0.52
At1g11960 unknown protein -0.52
At1g53160 transcription factor, putative -0.52
At4g31000 calmodulin-binding protein -0.52
At5g50570 putative protein -0.52
At5g22920 PGPD14 protein -0.52
At4g28190 expressed protein -0.52
At2g40435 unknown protein -0.52
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At5g06870 polygalacturonase inhibiting protein (PGIP2) -0.52
At5g05600 2-oxoglutarate-dependent dioxygenase family -0.53
At4g27280 putative protein -0.53
At1g12090 pEARLI 1-like protein -0.53
At1g70090 expressed protein -0.53
At4g38550 Phospholipase like protein -0.53
At2g02950 expressed protein -0.53
At5g66590 putative protein -0.53
At3g16400 putative lectin -0.53
At2g38750 putative annexin -0.53
At1g10020 unknown protein -0.54
At4g00970 Similar to receptor kinase -0.54
At1g78100 expressed protein -0.54
At3g54920 polysaccharide lyase family 1 (pectate lyase) -0.54
At3g57930 putative protein -0.54
At3g57120 putative protein -0.54
At2g03240 unknown protein -0.54
At5g53500 putative protein -0.54
At1g29690 expressed protein -0.55
At2g03260 unknown protein -0.55
At1g17620 expressed protein -0.55
At2g34770 fatty acid hydroxylase (FAH1) -0.55
At5g66580 putative protein -0.56
At4g02330 hypothetical protein -0.56
At1g22335 glycine-rich RNA-binding protein, putative -0.56
At3g44870 methyltransferase-related -0.56
At1g11210 expressed protein -0.56
At4g31800 WRKY family transcription factor -0.56
At5g37540 putative protein -0.56
At1g35350 unknown protein -0.56
At1g65450 expressed protein -0.56
At1g75900 family II extracellular lipase 3 (EXL3) -0.56
At1g66100 thionin, putative -0.56
At1g08920 putative sugar transport protein, ERD6 -0.57
At3g58850 putative protein -0.57
At1g72430 expressed protein -0.57
At5g64260 phi-1-like protein -0.57
At2g28630 beta-ketoacyl-CoA synthase family -0.58
At1g29395 Expressed protein -0.59
At4g18010 putative protein -0.59
At1g20510 expressed protein -0.59
At2g24850 putative tyrosine aminotransferase -0.59
At4g38400 putative pollen allergen -0.59
At3g51450 strictosidine synthase-related -0.59
At1g66160 expressed protein -0.6
At1g67900 unknown protein -0.6
At1g11260 glucose transporter -0.6
At1g36280 adenylosuccinate lyase-like protein -0.61
At5g56980 putative protein -0.61
At1g03300 unknown protein -0.61
At2g01300 predicted by genscan and genefinder -0.61
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At5g22380 NAC-domain protein-like -0.61
At3g55980 putative protein -0.61
At5g66200 putative protein -0.61
At5g45750 GTP-binding protein, putative -0.61
At3g55430 glycosyl hydrolase family 17 (beta-1,3-glucanase) -0.61
At1g19180 expressed protein -0.61
At1g52400 glycosyl hydrolase family 1, beta-glucosidase (BG1) -0.61
At5g24780 vegetative storage protein Vsp1 -0.62
At2g39400 putative phospholipase -0.62
At1g63750 disease resistance protein (TIR-NBS-LRR class), putative -0.62
At2g39420 putative phospholipase -0.62
At2g24600 expressed protein -0.62
At3g28220 unknown protein -0.62
At1g80440 expressed protein -0.63
At4g18440 adenylosuccinate lyase - like protein -0.63
At2g34510 unknown protein -0.63
At5g19140 aluminium-induced protein - like -0.63
At1g53430 receptor-like serine/threonine kinase, putative -0.63
At2g25460 expressed protein -0.63
At5g20250 glycosyl hydrolase family 36 -0.64
At1g72180 leucine-rich repeat transmembrane protein kinase, putative -0.64
At5g01810 serine/threonine protein kinase ATPK10 -0.64
At4g26530 fructose-bisphosphate aldolase - like protein -0.64
At1g02205 hypothetical protein -0.64
At4g16780 homeobox-leucine zipper protein HAT4 (HD-Zip protein 4) -0.64
At2g15090 fatty acid elongase 1 (FAE1), putative -0.65
At1g17380 expressed protein -0.65
At1g32170 xyloglucan endotransglycosylase (XTR4), putative -0.65
At4g25810 xyloglucan endotransglycosylase (XTR-6) -0.65
At3g28180 expressed protein -0.65
At2g35930 unknown protein -0.65
At3g09940 monodehydroascorbate reductase, putative -0.65
At5g12050 putative serine rich protein -0.65
At1g04240 putative auxin-induced protein AUX2-11 -0.66
At4g30270 xyloglucan endotransglycosylase (meri5B) -0.66
At2g22770 putative bHLH transcription factor -0.66
At1g54010 myrosinase-associated protein, putative -0.67
At5g19190 putative protein -0.67
At1g63880 disease resistance protein (TIR-NBS-LRR class), putative -0.67
At3g59080 putative protein -0.68
At5g58670 phosphoinositide specific phospholipase C -0.68
At4g35770 senescence-associated protein sen1 -0.68
At4g27100 putative protein -0.69
At4g27450 putative protein -0.7
At1g18740 expressed protein -0.7
At1g02380 hypothetical protein -0.7
At1g01120 fatty acid elongase 3-ketoacyl-CoA synthase 1 (KCS1) -0.7
At1g74450 expressed protein -0.7
At4g17500 ethylene responsive element binding factor 1 (frameshift !) -0.7
At1g22530 unknown protein -0.71
At5g45340 cytochrome p450 family -0.71
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At2g42980 putative chloroplast nucleoid DNA binding protein -0.71
At5g52900 expressed protein -0.71
At3g50060 myb DNA-binding protein (MYB77) -0.71
At1g70290 trehalose-6-phosphate synthase, putative -0.72
At3g62630 putative protein -0.72
At4g17230 scarecrow-like 13 (SCL13) -0.72
At1g61120 terpene synthase/cyclase family -0.72
At3g50260 putative protein -0.73
At5g62165 MADS-box protein -0.73
At3g15540 early auxin-induced protein, IAA19 -0.73
At5g25240 putative protein -0.74
At5g47240 mutT domain protein-like -0.74
At5g54380 receptor-protein kinase-like protein -0.74
At3g62550 putative protein -0.74
At2g42580 expressed protein -0.75
At5g67480 putative protein -0.75
At5g50950 fumarate hydratase -0.75
At1g61100 disease resistance protein (TIR class), putative -0.75
At5g24770 vegetative storage protein Vsp2 -0.75
At1g66180 expressed protein -0.76
At5g45820 serine threonine protein kinase -0.77
At3g06500 neutral invertase, putative -0.77
At3g54810 GATA zinc finger protein -0.78
At4g37260 myb DNA-binding protein (AtMYB73) -0.78
At2g18700 putative trehalose-6-phosphate synthase -0.78
At1g18710 myb-related transcription factor mixta, putative -0.78
At2g30930 expressed protein -0.79
At3g55840 nematode resistance protein-like protein -0.79
At2g35290 hypothetical protein -0.8
At2g41640 expressed protein -0.8
At2g39030 expressed protein -0.8
At1g72150 cytosolic factor, putative -0.81
At1g17420 lipoxygenase -0.81
At4g34410 putative protein -0.81
At1g58270 expressed protein -0.82
At5g67300 myb family transcription factor -0.82
At1g72450 expressed protein -0.82
At5g49360 glycosyl hydrolase family 3 -0.83
At1g70820 phosphoglucomutase, putative -0.83
At3g26740 light regulated protein, putative -0.84
At1g68600 expressed protein -0.84
At3g11480 S-adenosyl-L-methionine:carboxyl methyltransferase family -0.84
At2g17840 putative senescence-associated protein 12 -0.84
At4g32280 Expressed protein -0.85
At1g02610 hypothetical protein -0.87
At3g06070 expressed protein -0.88
At1g23030 unknown protein -0.89
At5g51550 putative protein -0.89
At2g34930 disease resistance protein family -0.89
At1g57990 unknown protein -0.89
At1g76650 putative calmodulin -0.89
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Table S4: continued 
AGI code description log ratio
At2g23290 MYB family transcription factor -0.91
At4g08950 putative phi-1-like phosphate-induced protein -0.91
At1g16370 putative transport protein -0.92
At1g52830 putative IAA6 protein -0.95
At3g62720 alpha galactosyltransferase-like protein -0.97
At2g27080 expressed protein -0.98
At4g03400 putative GH3-like protein -0.99
At4g37240 putative protein -1.0
At2g47440 unknown protein -1.0
At4g08040 strong similarity to 1-aminocyclopropane-1-carboxylic acid synthases -1.03
At1g50040 hypothetical protein -1.04
At1g10550 xyloglucan endotransglycosylase, putative -1.05
At5g25190 ethylene-responsive element - like protein -1.06
At2g44500 similar to axi 1 protein from Nicotiana tabacum -1.09
At4g17460 homeobox-leucine zipper protein HAT1 (HD-Zip protein 1) -1.13
At5g61590 ethylene responsive element binding factor - like -1.14
At4g16563 similar to chloroplast nucleoid DNA-binding protein-like -1.2
At2g17230 expressed protein -1.25
At2g27690 cytochrome p450, putative -1.34
At3g19680 unknown protein -1.42
At1g21910 TINY-like protein -1.44
At5g57560 xyloglucan endotransglycosylase (TCH4) -1.45
At1g35140 phosphate-induced (phi-1) protein, putative -1.52
At3g45970 putative protein -1.62
At1g33760 transcription factor TINY, putative -1.73
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Abbreviations 
1MOI3M   1- methoxyindol-3-ylmethyl glucosinolate 
4MOI3M   4-methoxyindol-3-ylmethyl glucosinolate 
4MSOB   4-methylsulfinylbutyl glucosinolate 
8MSOO   8-methysulfinyloctyl glucosinolate 
3MSOP   3-methylsulfinylpropyl glucosinolate 
5MSOP   5- methylsulfinylpropyl glucosinolate 
5MT   5-methyl tryptophan 
4MU   4-methylumbelliferone 
35S   35S promoter of the cauliflower mosaic virus 
aa    amino acids 
AAO1   indole-3-acetaldehyde oxidase 
ACC   1-aminocyclopropane-1-carboxylic acid 
AD   activation domain 
AGI    Arabidopsis Genome Initiative number 
A. thaliana  Arabidopsis thaliana 
ATR   altered tryptophan regulation 
AtST   A. thaliana sulof transferase 
A. tumefaciens   Agrobacterium tumefaciens 
Arabidopsis   Arabidopsis thaliana 
ASA1   anthranilate synthase alpha 1 
ASB1   anthranilate synthase beta 1 
BD   binding domain 
bHLH   basic helix-loop-helix 
bp    base pairs 
BSA    bovine serum albumin 
BY2    bright yellow 2 
°C    centigrade 
CaMV   cauliflower mosaic virus 
cDNA    complementary DNA 
CDS   coding sequence 
ChlorR   chloramphenicol resistance 
cRNA^   complementary RNA 
cm    centimetre 
Col-0    Columbia 0 
CYP   cytochrome P450 monooxygenase 
DAHP   3-deoxy-D-arabinoheptulosonate-7-phosphate 
DHS1   DAHP synthase 1 
DNA    desoxyribonucleic acid 
dd    double distilled 
DEPC    diethylpyrocarbonate 
DMF    dimethylformamide 
DMSO    dimethyl-sulfoxide 
dNTPs    deoxynucleotides 
DTT    di-thiotreitol 
E. coli    Escherichia coli 
EDTA    ethylendiaminetetraacetic acid 
GentR   gentamycin 
GFP    green fluorescent protein 
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GS   glucosinolate 
GST   glutathione-S-transferase 
GUS    β-glucuronidase 
HEPES    N-2-Hydroxyethylpiperazin-N´-2-ethansulfonic acid 
IAA   indole-3-acetic acid 
IAAld   indole-3-acetaldehyde 
IAN   indole-3-acetonitrile 
IAOx   indole-3-acetaldoxime 
IGPS   indole-3-glycerolphosphate synthase 
I3M   indole-3-ylmethyl glucosinolate 
kDa    kilo Daltons 
kg    kilograms 
L   litre 
LB    Luria-Bertani medium 
Ler   Landsberg erecta 
M    molar 
MeJA   methyl jasmonate 
MES    4-morpholinoethan-sulphonic acid 
mg    milligram 
μF    micro Faraday 
μg    microgram 
μl    microlitre 
min    minute 
mL    millilitre 
mM    millimolar 
mRNA    messenger RNA 
MS    Murashige and Skog 10 medium 
MUG   4-methylumbelliferyl-β-D-glucuronide 
MYR   myrosinase 
N. benthamiana   Nicotiana benthamiana 
n   number of experiments 
ng    nanogram 
NIT   nitrilase 
Ω    Ohm 
ORF    open reading frame 
PCR    polymerase chain reaction 
PEG    polyethylenglycol 
QTL   quantitative trait loci 
RifR   rifampicin 
RNA    ribonucleic acid 
rpm    revolutions per minute 
RT    room temperature 
RT-PCR   reverse transcribed PCR 
SA   salicylic acid 
S. cerevisiae   Saccharomyces cerevisiae 
S. exigua  Spodoptera exigua 
SD   standard deviation  
SD-medium  single drop-out medium 
SDS    sodium docecyl sulphate 
sec    seconds 
ss   single stranded 
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ST   sulfo transferase 
SUR   superroot 
TAE   Tris-Acetate/EDTA 
T-DNA    Transfer DNA 
TE    Tris/EDTA 
TGG   β-thioclucoside glycohydrolase (=MYR) 
Tris    tris-(hydroxymethyl)-aminomethan 
TSB1   tryptophan synthase beta 1 
U    units (enzymatic) 
UGT   S-glucosyl transferase 
v/v    volume/volume 
w/v    weight/volume 
wt    wild-type 
x g    times gravity 
X-Gluc    5-bromo-4-chloro-3-indoly-β-D-glucoronid acid 
YFP    yellow fluorescent protein 
YUCCA   flavin monooxygenase-like protein 
#   number 
(nucleotides and amino acids are abbreviated according to international conventions) 
Abstract   
 
107
Abstract 
Glucosinolates are amino-acid derived plant secondary metabolites found mainly in 
Brassicaceae, including the model plant Arabidopsis thaliana. Due to their role in 
plant defence and their cancer-preventive properties in human nutrition, they have 
gained increasing interest over the last years. This study presents the 
characterisation of the activation-tagging mutant HIG1-1D, which displays a high 
indolic glucosinolate phenotype, caused by an activation of the R2R3-type MYB 
transcription factor HIG1/MYB51. A positive correlation between HIG1/MYB51 
transcription and the accumulation of indolic glucosinolates could be confirmed in 
gain and loss-of-function mutants. HIG1/MYB51 expression overlaps with sites of 
indolic glucosinolate biosynthesis and the expression of biosynthesis genes, which 
are activated by HIG1/MYB51 in trans. Unlike previously characterised mutants 
affected in indolic glucosinolate biosynthesis, HIG1-1D displays only minor effects on 
auxin biosynthesis. However, a role of HIG1/MYB51 in the biotic stress response of 
A. thaliana appears likely, due to the mechano-sensitive expression of HIG1/MYB51 
along with an increased resistance of HIG1-1D plants against a generalist herbivore.  
Yeast-two-hybrid screening allowed identifying the interaction of HIG1/MYB51 with 
ATR2/bHLH05, a putative regulator of tryptophan and indolic glucosinolate 
biosynthesis. Therefore, HIG1/MYB51 appears to be part of a complex network 
controlling indolic glucosinolate biosynthesis. 
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Kurzzusammenfassung 
Glucosinolate sind eine Gruppe pflanzlicher Sekundärmetabolite, die hauptsächlich 
in den Brassicaceaen vorkommen, unter anderem auch in Arabidopsis thaliana. 
Aufgrund ihrer Rolle in der pflanzlichen Pathogenabwehr und ihrer 
krebsvorbeugenden Eigenschaften haben Glucosinolate in den letzten Jahren an 
Bedeutung gewonnen. In der vorliegenden Studie wird die activation-tagging Mutante 
HIG1-1D charakterisiert, die aufgrund einer Aktivierung des R2R3-MYB 
Transkriptionsfaktors HIG1/MYB51 eine erhöhte Konzentration an Indol-
Glucosinolaten aufweist. Durch die Untersuchung von gain- und loss-of-function 
Mutanten konnte die positive Korrelation zwischen der Expression von HIG1/MYB51 
und der Akkumulation von Indol-Glucosinolaten bestätigt werden. HIG1/MYB51 wird 
in Geweben exprimiert, in denen Indol-Glucosinolate und die daran beteiligten 
Enzyme synthetisiert werden, deren Expression von HIG1/MYB51 induziert wird. 
Im Gegensatz zu bereits charakterisierten Mutanten, bei denen die Indol-
Glucosinolate Biosynthese dereguliert ist, scheint die Auxin Biosynthese in HIG1-1D 
nur wenig beeinflusst zu sein. Eine regulatorische Rolle von HIG1/MYB51 in der 
biotischen Stressantwort von A. thaliana scheint hingegen wahrscheinlich, da 
HIG1/MYB51 durch mechanische Reize induziert wird. Darüber hinaus, zeigen HIG1-
1D Pflanzen eine erhöhte Resistenz gegenüber unspezifischen Herbivoren.  
In einem yeast-two-hybrid Ansatz konnte die Interaktion von HIG1/MYB51 mit dem 
basic helix-loop-helix Transkriptions Faktor ATR2/bHLH05 gezeigt werden, welcher 
eine regulatorische Rolle in der Tryptophan und Glucosinolat Biosynthese hat. Es 
erscheint daher möglich, dass HIG1/MYB51 Teil eines regulatorischen Netzwerks ist, 
das die Biosynthese von Indol-Glucosinolaten kontrolliert.  
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